Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

F5_BEHEMOCHILD

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints F5_ADHD F5_HYPERKIN F5_CONDUCT F5_CONDUCTEMO F5_EMOCHILD F5_TIC F5_BEHEMOTH	13352
6. Filter based on genotype QC (FinnGen only)	11799

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	F5_BEHEMOCHILD
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	F5_ADHD\|F5_HYPERKIN\|F5_CONDUCT\|F5_CONDUCTEMO\|F5_EMOCHILD\|F5_TIC\|F5_BEHEMOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Behavioural and emotional disorders with onset usually occurring in childhood and adolescence based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	196519	79805	116396
Only index persons	167819	70482	97337
Unadjusted period prevalence (%)
Whole population	2.85	2.29	3.25
Only index persons	3.24	2.59	3.72
Median age at first event (years)
Whole population	11.12	13.30	9.58
Only index persons	12.07	14.24	10.50

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	11799	7677	4122
Unadjusted period prevalence (%)	2.43	2.73	1.89
Median age at first event (years)	20.66	22.92	16.45

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12204: Matched controls
106345

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F93.9

ICD-10 Finland

Childhood emotional disorder, unspecified

1520.1

321.0

328

F95.2

ICD-10 Finland

Combined vocal and multiple motor tic disorder [de la Tourette]

144.7

316.7

180

F39

ICD-10 Finland

Unspecified mood [affective] disorder

4.8

314.5

776

1483

N05AA02

ATC

levomepromazine; systemic

5.2

310.7

704

1249

N05CF01

ATC

zopiclone; oral

2.4

309.8

2890

12360

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.7

308.3

1102

2791

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

8.0

307.7

1017

1199

N06BA12

ATC

lisdexamfetamine; oral

43.2

307.7

1880

446

IBZ06

NOMESCO Finland

Evaluation concerning developmental neuropsychiatry

48.9

307.7

843

161

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.1

307.7

2044

6422

F95.9

ICD-10 Finland

Tic disorder, unspecified

77.8

307.7

202

P81

ICPC

Hyperkinetic disorder

13.0

307.7

874

625

N03AX09

ATC

lamotrigine; oral

4.8

307.7

1752

3585

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

4.4

307.7

1420

3101

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.9

307.7

3550

13046

N06BA04

ATC

methylphenidate; oral

47.2

307.7

5993

2132

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

6.3

307.7

1318

1998

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

4.1

307.7

1145

2598

C07AA05

ATC

propranolol; systemic

2.6

307.7

3587

14796

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

4.0

307.7

1055

2487

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

6.8

307.7

1019

1412

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

7.6

307.7

528

625

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

6.2

307.7

752

1116

N05AF03

ATC

chlorprothixene; systemic

6.5

307.7

628

882

N03AG01

ATC

valproic acid; systemic, rectal

4.2

307.7

1303

2947

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

6.4

307.7

732

1057

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

4.1

307.7

1074

2421

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

5.5

307.7

897

1517

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

48.5

307.7

2064

444

P01

ICPC

Feeling anxious/nervous/tense

2.6

307.7

4662

20560

N05AH04

ATC

quetiapine; oral

5.0

307.7

5169

13627

Z2445

NOMESCO Finland

Psychologist

5.2

307.7

1596

3003

N06AX26

ATC

vortioxetine; oral

3.4

307.7

2324

6930

Z3231

NOMESCO Finland

Registered nurse

2.5

307.7

3643

15443

N06AX11

ATC

mirtazapine; oral

3.0

307.7

5198

21304

ZY010

NOMESCO Finland

Hospital outpatient

4.9

307.7

1993

4060

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.6

307.7

733

888

P29

ICPC

Psychological sympt/compl other

3.6

307.7

3032

9021

IGY02

NOMESCO Finland

Psychiatric monitoring contact

6.0

307.7

1688

2758

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

6.1

307.7

1067

1636

F90.9

ICD-10 Finland

Hyperkinetic disorder, unspecified

34.1

307.7

572

153

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.9

307.7

2908

7836

F98.9

ICD-10 Finland

Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence

107.9

307.7

476

IGY99

NOMESCO Finland

Other psychiatric treatment contact

6.0

307.7

1147

1818

N05AX08

ATC

risperidone; systemic

5.7

307.7

1838

3192

N06AX21

ATC

duloxetine; oral

3.2

307.7

1928

5938

IGV01

NOMESCO Finland

Psychiatric network contact

7.2

307.7

608

766

P74

ICPC

Anxiety disorder/anxiety state

3.3

307.7

1735

5125

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

3.4

307.7

1741

4918

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

6.2

307.7

1458

2262

N06AB04

ATC

citalopram; systemic

3.0

307.7

2813

9700

N06BA02

ATC

dexamfetamine; oral

52.9

307.7

302

N05BA01

ATC

diazepam; systemic, rectal

3.4

307.7

1703

4775

N06AX16

ATC

venlafaxine; oral

3.8

307.7

3352

9682

F98.00

ICD-10 Finland

Nonorganic enuresis nocturna

82.8

307.7

510

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

4.9

307.7

1296

2520

P99

ICPC

Psychological disorders other

4.5

307.7

1103

2294

F61.0

ICD-10 Finland

Mixed personality disorders

6.9

307.7

609

808

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.3

307.7

1229

2708

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

5.8

307.7

1813

3093

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.5

307.7

4197

13815

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

6.3

307.7

1742

2743

SPAT1307

SPAT

Psychosocial counselling and guidance

2.6

307.7

2287

8578

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

4.8

307.7

1536

3078

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

4.3

307.7

1827

4194

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

6.0

307.7

4632

9769

N05AX12

ATC

aripiprazole; systemic

5.0

307.7

1818

3599

F92.0

ICD-10 Finland

Depressive conduct disorder

1008.6

307.7

553

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.3

307.7

1114

1984

F93.1

ICD-10 Finland

Phobic anxiety disorder of childhood

47.4

307.7

235

N06AB06

ATC

sertraline; oral

3.7

307.7

3088

8988

P03

ICPC

Feeling depressed

2.7

307.7

3316

13112

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

7.9

307.7

937

1112

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

5.4

307.7

746

1257

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.4

307.7

2175

5023

SPAT1240

SPAT

Therapeutic discussion

2.5

307.7

2817

11424

F93.89

ICD-10 Finland

Other childhood emotional disorders

324.3

307.7

1386

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.9

307.7

1690

3406

N05AH03

ATC

olanzapine; systemic

4.8

307.7

1977

4117

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.9

307.7

1122

2678

N06AX12

ATC

bupropion; oral

5.4

307.7

3196

6597

F84.5

ICD-10 Finland

Asperger syndrome

13.2

307.7

665

461

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.7

307.7

1176

2995

N06AB03

ATC

fluoxetine; oral

4.6

307.7

2569

5807

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.2

307.7

1414

2622

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

5.0

307.7

1076

2017

F92.9

ICD-10 Finland

Mixed disorder of conduct and emotions, unspecified

504.0

307.7

393

P76

ICPC

Depressive disorder

3.1

307.7

2068

6560

ZYC01

NOMESCO Finland

Remote contact by phone

4.0

307.7

1419

3422

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.2

307.7

4313

12252

N05BA04

ATC

oxazepam; oral

3.3

307.7

4366

15506

F90.0

ICD-10 Finland

Disturbance of activity and attention

59.7

307.7

7166

2473

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

4.7

307.7

2078

4435

F98.8

ICD-10 Finland

Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence

120.3

307.7

465

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.5

307.7

1348

2873

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

7.7

307.7

1268

1568

N06BA09

ATC

atomoxetine; oral

70.9

307.7

604

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

6.8

307.7

1199

1683

Z2446

NOMESCO Finland

Social worker

4.1

307.7

1693

3975

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.4

307.7

1735

3882

N06AB10

ATC

escitalopram; oral

2.9

307.7

4742

19281

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

6.4

304.2

548

779

F60.9

ICD-10 Finland

Personality disorder, unspecified

6.9

303.7

504

656

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

7.3

302.8

483

601

F31.8

ICD-10 Finland

Other bipolar affective disorders

5.0

293.4

680

1230

F99

ICD-10 Finland

Mental disorder, not otherwise specified

4.9

291.5

698

1299

IGP01

NOMESCO Finland

Psychiatric family contact

7.2

291.2

466

582

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

4.5

284.7

754

1526

F40.1

ICD-10 Finland

Social phobias

3.6

284.5

1041

2675

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

6.0

271.2

515

772

F90

ICD-10 Finland

Hyperkinetic disorders

16.6

267.3

245

131

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

4.6

266.5

684

1348

F92.8

ICD-10 Finland

Other mixed disorders of conduct and emotions

1221.5

265.3

272

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

4.9

263.5

629

1166

N03AE01

ATC

clonazepam; systemic

4.2

260.6

756

1642

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.0

259.5

598

1075

N05BE01

ATC

buspirone; oral

5.1

256.8

580

1024

F91.9

ICD-10 Finland

Conduct disorder, unspecified

298.5

253.2

270

N03AX16

ATC

[U] pregabalin

2.4

252.7

2053

8180

F34.1

ICD-10 Finland

Dysthymia

3.7

248.7

883

2218

N06AX22

ATC

agomelatine; oral

4.2

247.1

720

1568

N05BA12

ATC

alprazolam; oral

3.1

241.3

1140

3429

N05AN01

ATC

lithium; oral

4.7

241.1

605

1169

N01

ICPC

Headache

2.1

238.7

3164

15370

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

4.8

238.5

577

1081

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

3.2

234.9

1036

2989

N06AB05

ATC

paroxetine; oral

3.4

232.2

948

2607

IEV99

NOMESCO Finland

Other psychiatric network intervention

7.5

230.6

353

418

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

7.5

229.7

353

420

30660

ICD-8 Finland

Special symptoms not elsewhere classified, Enuresis

+∞

227.9

230

ICB06, ,

NOMESCO Finland

6.3

225.2

409

585

F98.02

ICD-10 Finland

Non-organic nocturnal and diurnal enuresis

1025.1

224.6

231

F90.8

ICD-10 Finland

Other hyperkinetic disorders

46.3

223.7

147

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

7.0

220.4

361

462

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.6

219.9

1450

5210

P06

ICPC

Sleep disturbance

2.2

217.8

2318

10303

F51.0

ICD-10 Finland

Nonorganic insomnia

2.0

217.3

3168

15846

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

5.8

214.9

424

659

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.6

214.5

552

1088

P19

ICPC

Drug abuse

5.4

212.6

451

751

B18.2

ICD-10 Finland

Chronic viral hepatitis C

6.3

210.1

381

544

N06AX05

ATC

trazodone; oral

4.8

209.5

507

949

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

6.6

209.2

362

492

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

208.7

5321

31804

IAZ98

NOMESCO Finland

Other internal psychiatric consultation

12.0

208.6

228

169

F98.01

ICD-10 Finland

Non-organic diurnal enuresis

388.7

208.6

220

F32.1

ICD-10 Finland

Moderate depressive episode

2.4

204.8

1628

6379

N05AB03

ATC

perphenazine; systemic, rectal

4.3

201.8

564

1187

F83

ICD-10 Finland

Mixed specific developmental disorders

6.5

201.1

353

487

N07BB01

ATC

disulfiram; oral

3.7

201.1

694

1705

F98.5

ICD-10 Finland

Stuttering [stammering]

57.0

194.5

123

A04

ICPC

Weakness/tiredness general

2.0

193.7

2691

13157

F50.9

ICD-10 Finland

Eating disorder, unspecified

4.4

193.3

522

1069

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

6.4

191.8

339

471

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.9

190.2

973

3050

N02BF02

ATC

pregabalin; oral

3.0

189.2

903

2721

G04BD04

ATC

oxybutynin; oral, transdermal

4.6

187.8

475

922

F32

ICD-10 Finland

Depressive episode

2.5

187.1

1316

4860

N05CF02

ATC

zolpidem; oral

2.2

187.0

1898

8231

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.8

185.4

1051

3482

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.0

185.1

915

2812

F81.3

ICD-10 Finland

Mixed disorder of scholastic skills

8.2

182.9

260

281

D01

ICPC

Abdominal pain/cramps general

2.0

181.9

2436

11724

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.5

181.1

479

964

N03AX12

ATC

[U] gabapentin; oral

2.4

180.0

1450

5696

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.0

179.8

418

755

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

4.6

178.9

455

887

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.0

177.8

880

2705

R51.80

ICD-10 Finland

Headache

1.9

177.1

2800

14252

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

176.3

3823

21492

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

176.1

9745

71535

SPAT1254

SPAT

Administration of medicine

2.1

176.0

2147

9976

SPAT1389

SPAT

Visit based on need for special support

2.7

175.4

1077

3716

IGY02, ,

SPAT

4.3

173.9

488

1029

L17

ICPC

Foot/toe symptom/complaint

1.8

173.6

3588

19864

30899

ICD-8 Finland

Behaviour disorders of childhood

+∞

173.3

175

N05AD01

ATC

haloperidol; systemic

5.1

173.0

385

669

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

5.3

171.6

366

612

X78

ICD-10 Finland

Intentional self-harm by sharp object

6.8

171.0

287

377

R53

ICD-10 Finland

Malaise and fatigue

1.8

170.3

3529

19531

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.0

169.1

520

1175

Z71.8

ICD-10 Finland

Other specified counselling

1.7

168.7

5122

31590

F81.0

ICD-10 Finland

Specific reading disorder

7.1

168.1

269

335

SPAT1243

SPAT

Psychiatric/psychological examination

2.9

166.1

871

2762

F98.2

ICD-10 Finland

Feeding disorder of infancy and childhood

1563.9

166.1

170

A01

ICPC

Pain general/multiple sites

2.5

164.7

1222

4616

Z3226

NOMESCO Finland

Physiotherapist

2.1

164.4

1876

8482

Z07

ICPC

Education problem

4.6

164.3

420

822

F84.9

ICD-10 Finland

Pervasive developmental disorder, unspecified

11.9

163.5

179

133

F84.8

ICD-10 Finland

Other pervasive developmental disorders

16.7

162.4

148

F98.0

ICD-10 Finland

Nonorganic enuresis

221.1

161.5

175

IER01

NOMESCO Finland

Psychoeducation, group

5.2

160.8

350

596

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

5.4

158.8

333

548

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

158.0

1959

9124

IEY01

NOMESCO Finland

Psychoeducation, individual

5.0

157.5

364

654

Z2221

NOMESCO Finland

Medical doctor

1.8

157.4

3168

17308

R5599

NOMESCO Finland

Other rehabilitation service

4.4

156.8

421

857

N05CD07

ATC

temazepam; oral

3.6

156.6

560

1406

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.2

156.4

664

1862

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

154.9

1322

5308

F81.9

ICD-10 Finland

Developmental disorder of scholastic skills, unspecified

8.0

154.8

225

250

XA800

NOMESCO Finland

Neuropsychological investigation

3.2

154.4

662

1867

Z61.8

ICD-10 Finland

Other negative life events in childhood

12.5

153.5

163

115

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

153.4

10033

75356

R02

ICPC

Shortness of breath/dyspnoea

2.2

153.1

1541

6623

N06AX03

ATC

mianserin; oral

3.9

152.1

472

1073

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.8

152.0

370

695

L12

ICPC

Hand/finger symptom/complaint

1.9

151.9

2536

13054

F93.80

ICD-10 Finland

Generalized anxiety in the bardom age

466.5

151.7

159

Z72.2

ICD-10 Finland

Drug use

6.3

151.6

270

378

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

151.5

2247

11125

ZY000

NOMESCO Finland

Hospital inpatient

4.3

151.1

415

860

R03AC02

ATC

salbutamol; inhalant

1.6

150.1

6833

46315

IEP99

NOMESCO Finland

Other psychiatric family intervention

8.2

149.7

212

228

K02.1

ICD-10 Finland

Caries of dentine

1.7

149.0

8660

62483

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

148.6

2572

13381

P27

ICPC

Fear of mental disorder

4.0

147.0

445

993

F82

ICD-10 Finland

Specific developmental disorder of motor function

7.0

147.0

239

303

N05AH02

ATC

clozapine; systemic

3.8

146.9

472

1100

WX290

NOMESCO Finland

Other blockage of nerve

1.7

146.4

7703

54001

T74.1

ICD-10 Finland

Physical abuse

3.4

146.2

570

1514

A05

ICPC

Feeling ill

2.1

145.7

1735

7942

P23

ICPC

Adolescent behaviour sympt/compl

6.4

145.7

258

359

M79.7

ICD-10 Finland

Fibromyalgia

3.5

143.4

543

1415

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.9

142.2

719

2231

N05BA06

ATC

lorazepam; systemic, sublingual

3.6

142.0

497

1229

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

142.0

2138

10616

M79.6

ICD-10 Finland

Pain in limb

1.6

141.7

4881

30694

N02AX02

ATC

tramadol; systemic, rectal

1.7

140.8

3472

19994

F31

ICD-10 Finland

Bipolar affective disorder

4.5

140.7

364

719

IHZ05, ,

SPAT

2.1

140.4

1465

6373

-1, ,

NOMESCO Finland

1.6

140.1

5430

35131

L03

ICPC

Low back symptom/complaint

1.7

139.9

3848

22814

Z63.5

ICD-10 Finland

Disruption of family by separation and divorce

7.5

139.3

212

249

S18

ICPC

Laceration/cut

1.6

137.6

4426

27298

Z63.8

ICD-10 Finland

Other specified problems related to primary support group

9.7

137.1

171

155

A29

ICPC

General symptom/complaint other

2.1

135.8

1447

6341

D09

ICPC

Nausea

2.2

133.3

1262

5276

AA1AD

NOMESCO Finland

CT of head and brain

1.9

133.3

1894

9205

EBA00

NOMESCO Finland

Extraction of tooth

1.6

133.1

5445

35543

SPAT1310

SPAT

Counselling related to known health issue

1.6

131.8

4134

25265

IHZ04, ,

SPAT

3.3

131.4

527

1424

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

7.9

131.2

192

215

F33

ICD-10 Finland

Recurrent depressive disorder

2.9

130.9

670

2091

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

130.7

5742

38065

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

3.3

130.6

522

1408

F41.3

ICD-10 Finland

Other mixed anxiety disorders

3.2

130.0

564

1600

A97

ICPC

No disease

1.7

129.8

2809

15537

SPAT1396

SPAT

Meeting with multidisciplinary group of experts

5.7

129.5

255

395

R21

ICPC

Throat symptom/complaint

1.6

129.2

4757

30207

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

6.9

128.9

213

275

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

7.6

128.8

194

225

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

4.3

128.0

355

741

G47.3

ICD-10 Finland

Sleep apnoea

1.9

127.4

1892

9319

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

126.8

6001

40371

R05

ICPC

Cough

1.7

126.3

3311

19276

SFA10

NOMESCO Finland

One-surface restoration

1.6

126.1

7636

54371

F60.8

ICD-10 Finland

Other specific personality disorders

6.3

126.0

224

313

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

4.7

125.7

307

578

SPAT1283

SPAT

Restricted health certificate

1.6

125.0

4074

25061

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

124.4

6716

46488

C07AB07

ATC

bisoprolol; oral

1.8

124.2

2507

13568

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.5

123.7

322

639

IBB01

NOMESCO Finland

Psychiatric functioning capacity evaluation

7.0

123.4

199

250

F41.00

ICD-10 Finland

Moderate panic disorder

3.5

123.1

446

1128

F90.1

ICD-10 Finland

Hyperkinetic conduct disorder

196.7

122.9

134

N04AA02

ATC

biperiden; systemic

4.8

122.8

291

534

S06.0

ICD-10 Finland

Concussion

2.0

122.0

1598

7535

A02BC02

ATC

pantoprazole; systemic

1.6

121.9

6095

41378

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.5

121.9

834

3019

R74

ICPC

Upper respiratory infection acute

1.6

121.5

6236

42575

F32.8

ICD-10 Finland

Other depressive episodes

3.7

121.3

416

1014

N06AA12

ATC

doxepin; systemic

4.1

120.1

354

774

G43.9

ICD-10 Finland

Migraine, unspecified

2.0

120.0

1396

6306

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

119.9

3547

21249

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

119.8

993

3920

SPAT1234

SPAT

Support of social functional capacity

3.4

119.7

463

1222

IAB03

NOMESCO Finland

Neuropsychiatric consultation

24.7

119.6

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

4.2

119.5

343

735

R06.0

ICD-10 Finland

Dyspnoea

1.8

118.7

2334

12516

P15

ICPC

Chronic alcohol abuse

3.2

118.3

498

1386

F91.2

ICD-10 Finland

Socialized conduct disorder

365.0

118.3

125

R4110, ,

SPAT

2.2

117.6

1098

4554

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

117.0

2968

17073

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3044889) 12 lead EKG panel

7639

47119

2.10

321.36

3.2

2.6

0.00

13291.71

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5370

26745

2.34

307.65

7.6

6.4

1.22

1.21

mmol/l

12.21

5040

25083

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10467

71791

2.90

307.65

5.3

4.2

14.35

14.34

pmol/l

0.05

9915

67013

(3021960) Folate [Moles/volume] in Serum or Plasma

3647

16404

2.34

307.65

1.7

1.5

18.62

19.36

nmol/l

1.72

3298

14895

(3009508) Creatinine [Moles/volume] in Urine

4961

21042

2.78

307.65

4.4

3.6

8.55

8.89

mmol/l

3.21

4408

19189

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8917

56406

2.40

307.65

7.1

6.7

76.82

73.65

u/l

9.86

8496

53708

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5406

28475

2.17

307.65

3.8

3.2

29.52

29.50

u/l

0.01

5144

27241

(3015377) Calcium [Moles/volume] in Serum or Plasma

4325

21263

2.20

307.65

2.5

2.8

2.35

mmol/l

0.90

4024

19882

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2122

4951

4.31

307.65

2.0

1.7

0.19

0.26

mg/l

8.44

933

2229

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

4739

15613

3.69

307.65

2.2

1.7

1.46

1.34

25.12

4302

14284

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5268

27171

2.21

307.65

2.0

1.7

98.32

97.79

pmol/l

0.37

3124

15562

(3011288) Drugs identified in Urine by Screen method Nominal

3619

7907

5.25

307.65

4.6

2.6

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5977

30425

2.40

307.65

7.6

6.6

1.22

1.21

mmol/l

5.81

5256

26703

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1005

1403

6.71

307.65

2.3

2.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

11200

82042

3.30

304.37

14.7

9.6

139.60

139.48

mmol/l

8.93

11009

79931

(3023103) Potassium [Moles/volume] in Serum or Plasma

11209

82188

3.31

303.09

14.8

9.7

3.89

3.90

mmol/l

0.67

10983

79821

(4198724) Urine methamphetamine measurement

604

976

5.62

294.80

2.9

2.8

—

(3018418) pH of Serum or Plasma

3599

17294

2.15

287.99

3.7

3.9

7.39

1.47

2480

11681

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

11150

82035

3.13

287.43

6.6

4.9

1.70

1.72

mu/l

0.97

10781

78720

(3019309) Folate [Moles/volume] in Red Blood Cells

1957

7321

2.58

277.37

1.7

1.6

1095.74

1160.09

nmol/l

2.55

1558

5737

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6074

35778

1.95

272.20

5.4

5.2

10.16

10.93

umol/l

4.01

5650

33640

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6182

36712

1.95

269.48

3.0

2.5

67.37

70.36

nmol/l

15.11

5850

35033

(3024561) Albumin [Mass/volume] in Serum or Plasma

4963

28035

1.91

243.63

4.8

5.1

37.95

37.88

g/l

0.37

4630

26536

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3349

16712

2.03

233.98

2.5

2.1

225.58

234.60

u/l

0.16

3201

16033

(3013650) Neutrophils [#/volume] in Blood by Automated count

7573

49490

1.88

230.73

11.1

8.9

4.02

3.95

e9/l

2.14

6576

43329

(3013115) Eosinophils [#/volume] in Blood

7185

46268

1.86

228.20

8.2

6.9

0.19

0.18

e9/l

0.37

6334

41494

(3013826) Glucose [Moles/volume] in Serum or Plasma

6902

43897

1.85

228.04

5.7

4.6

6.12

6.19

mmol/l

1.78

6428

39117

(3013512) EKG study

3184

15805

2.02

224.20

2.7

2.3

—

0.78

—

(3006315) Basophils [#/volume] in Blood

6971

44692

1.84

221.78

7.5

6.7

0.04

e9/l

0.18

6036

39504

(3001604) Monocytes [#/volume] in Blood

6959

44670

1.83

219.55

7.5

6.7

0.55

0.54

e9/l

3.24

6029

39523

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

10273

75082

2.22

218.75

4.4

3.2

5.62

5.51

mmol/l

10.57

9750

71243

(3019069) Monocytes/Leukocytes in Blood

6515

41202

1.81

213.33

7.4

6.8

8.13

8.27

4.52

6119

39193

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4139

22773

1.88

213.14

3.0

2.6

53.67

57.74

u/l

2.29

3801

21296

(3009466) Valproate [Moles/volume] in Serum or Plasma

606

1298

4.23

212.06

6.1

6.3

372.49

386.63

umol/l

1.26

546

1159

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

9425

66982

1.99

211.95

4.4

2.9

33.65

32.56

u/l

1.17

9076

64785

(3022096) Basophils/Leukocytes in Blood

6485

41015

1.81

211.63

7.5

6.8

0.65

0.67

1.09

6082

38878

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3863

20840

1.90

210.93

2.5

2.3

2.47

2.48

mg/l

0.07

3390

18216

(3006504) Eosinophils/Leukocytes in Blood

6480

41112

1.80

207.70

7.4

6.7

2.73

2.78

1.06

6078

39050

(3019150) Specific gravity of Urine by Refractometry

4011

22074

1.87

204.55

3.7

3.0

1.02

1.31

kg/l

1.35

2599

13706

(3019198) Lymphocytes [#/volume] in Blood

7101

46411

1.80

204.52

7.6

6.6

2.11

2.03

e9/l

4.62

6303

42029

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

8635

59910

1.88

204.14

4.3

3.7

7.95

7.66

mm/h

2.03

8137

56864

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1989

8684

2.19

193.25

2.1

372.44

384.65

nmol/l

1.96

1852

8131

(3002030) Lymphocytes/Leukocytes in Blood

6686

43379

1.76

192.28

7.4

6.6

31.05

30.71

1.98

6348

41683

(3018010) Neutrophils/Leukocytes in Blood

6586

42674

1.75

188.88

7.2

6.4

54.79

55.38

4.37

6298

41243

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2515

12209

2.00

183.45

1.7

1.5

14846990.72

38208797.07

pmol/l

2.30

2216

10817

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4839

29553

1.71

163.81

1.6

1.4

1.79

1.69

u/ml

0.17

1242

8577

(3024666) Lithium [Moles/volume] in Serum or Plasma

440

912

4.32

160.20

12.0

13.1

0.60

0.59

mmol/l

0.67

403

847

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1781

8024

2.09

156.99

8.0

7.4

1.12

1.10

mmol/l

1.42

1670

7583

(3042517) Benzodiazepines panel - Urine

220

246

7.92

150.56

2.7

3.0

—

(3002582) Erythrocytes [#/volume] in Urine

3967

23373

1.71

149.87

3.5

3.0

53.06

61.45

e6/l

0.27

2975

17000

(3020564) Creatinine [Moles/volume] in Serum or Plasma

11595

92505

2.85

144.36

15.4

10.6

68.63

69.57

umol/l

4.12

11498

91432

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2062

10077

1.94

143.75

2.0

2.3

2.40

mmol/l

0.41

1799

8968

(3032080) INR in Blood by Coagulation assay

4038

24164

1.68

142.26

5.7

6.2

1.05

1.08

inr

7.65

3422

20085

(3007164) IgA [Mass/volume] in Serum or Plasma

4169

25284

1.66

138.70

1.6

1.5

1.97

2.06

g/l

4.90

2527

16907

(3015736) pH of Urine

5873

38859

1.61

137.14

3.8

2.9

6.30

6.26

1.64

3444

21775

(3030467) Casts [#/volume] in Urine by Automated count

3498

20318

1.70

136.62

3.4

2.9

0.24

0.26

e6/l

0.25

2521

14083

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

10269

78562

1.88

134.86

11.6

8.4

103.66

100.79

ml/min/173m2

42.26

9153

68628

(3021589) Normoblasts [#/volume] in Blood

6015

40135

1.60

134.70

11.3

9.3

0.00

e9/l

0.92

4849

32841

(40758558) Short blood count panel - Blood

3934

23662

1.66

134.08

6.8

5.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11569

93035

2.61

123.80

11.7

8.5

28.04

26.84

u/l

6.31

11355

90941

(36304419) Bacteria [Presence] in Urine

3408

20078

1.66

123.78

3.4

2.8

0.98

33.41

estimate

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1972

9941

1.87

123.30

5.6

4.3

0.82

0.83

mmol/l

1.90

1843

9501

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5100

33243

1.58

121.82

3.0

2.3

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

409

986

3.71

121.15

22.8

1349.03

2305.32

nmol/l

0.49

404

954

(3018095) Leukocytes [#/volume] in Urine

4718

30301

1.58

119.41

4.3

3.5

60.14

54.21

e6/l

0.27

3199

19012

(3022948) Iron [Moles/volume] in Serum or Plasma

2184

11485

1.80

118.66

2.7

2.4

14.80

15.08

umol/l

0.95

2050

10833

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7585

54321

1.57

118.16

3.9

3.3

65.97

69.28

ug/l

1.78

7228

52151

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2026

10441

1.83

117.54

2.7

2.4

2.52

2.50

g/l

0.88

1850

9728

(3000850) Epithelial cells [#/volume] in Urine

2751

15532

1.70

116.12

2.8

2.5

9.56

7.72

e6/l

3.37

2489

13926

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

5384

35930

1.55

113.09

3.1

2.5

—

(3026782) Osmolality of Urine

2453

13506

1.73

113.05

2.8

2.6

550.75

550.10

mosm/kgh2o

0.04

2177

11803

(3023368) Bacteria identified in Blood by Culture

2736

15553

1.69

112.00

4.2

3.8

—

(3002032) Base excess in Venous blood by calculation

1341

6154

2.01

109.85

6.9

5.5

1.19

1.42

mmol/l

1.72

1155

5222

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1365

6319

1.99

109.06

6.7

5.4

5.89

5.84

kpa

1.22

1319

6151

(3019225) pH of Specimen

1070

4527

2.16

108.75

3.6

3.2

7.35

0.22

831

3249

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

9440

71781

1.64

108.34

4.8

3.8

36.35

36.22

mmol/mol

0.64

8964

69217

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1059

4471

2.17

108.19

7.2

4.9

5.11

5.07

kpa

1.13

1016

4321

(3009343) pH of Capillary blood

1042

4382

2.17

107.48

7.2

5.0

7.41

2.05

869

3642

(3023511) Choriogonadotropin [Units/volume] in Urine

1384

6481

1.97

106.89

1.5

1.4

—

(3026008) Bacteria identified in Urine by Culture

3560

21839

1.59

106.62

2.8

2.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

1207

5404

2.05

105.63

6.3

5.1

4.98

4.86

kpa

0.87

1161

5258

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1253

5690

2.02

105.47

2.9

0.23

g/l

1.18

1165

5373

(3012544) pH of Venous blood

1345

6306

1.96

103.32

6.7

5.4

7.37

0.86

803

3750

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1809

9336

1.81

103.24

2.8

2.5

23.76

24.49

1.47

1679

8771

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

256

491

4.62

102.48

3.9

2.9

183.16

164.74

umol/l

0.29

135

241

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1033

4477

2.10

98.31

7.5

5.7

23.88

23.95

mmol/l

0.37

1016

4441

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3406

21011

1.57

97.90

2.9

2.4

105.19

38.64

ng/l

0.41

1432

7952

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

953

4019

2.16

97.28

7.4

5.0

0.96

1.04

mmol/l

0.30

645

2790

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1101

4942

2.03

95.26

12.7

10.2

24.63

24.54

mmol/l

0.39

1096

4912

(3031040) Bacteria [#/volume] in Urine by Automated count

7821

57722

1.50

93.83

5.0

3.9

979.07

1322.23

e6/l

0.32

137

703

(3033658) Prothrombin time (PT) actual/Normal

3053

18526

1.58

93.42

5.1

4.0

94.68

94.57

0.09

2979

18060

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11216

90418

2.00

93.31

14.8

10.4

19.24

20.28

mg/l

3.08

9140

70884

(36660697) Celiac disease serology panel - Serum

1869

10080

1.73

90.60

1.3

1.2

—

(3000991) Gas panel - Venous blood

1207

5693

1.94

90.49

12.1

9.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

8131

60754

1.50

89.39

4.7

3.9

3.34

11.17

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2489

14537

1.62

88.70

1.4

1.3

5.45

7.60

u/ml

1.51

949

6098

(3037522) Nuclear Ab [Titer] in Serum

2308

13255

1.64

87.93

1.5

1.4

398.35

545.65

titre

4.25

340

2433

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2694

16079

1.59

87.57

1.4

1.3

21.42

20.79

iu/ml

0.08

597

4220

(3048689) Calprotectin [Mass/mass] in Stool

2816

17047

1.57

85.87

2.5

3.0

98.78

112.67

ug/g

1.54

2113

13740

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1452

7414

1.80

84.61

2.5

2.6

36.02

46.77

u/l

0.56

1223

6373

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2053

11585

1.65

83.33

3.2

2.6

4.82

4.10

e6/l

1.41

953

5121

(3014111) Lactate [Moles/volume] in Serum or Plasma

1108

5229

1.93

82.59

9.8

8.7

1.35

1.32

mmol/l

0.40

1084

5137

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1884

10424

1.68

82.40

3.4

2.8

273.76

507.38

ng/l

2.77

844

4998

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

234

504

4.11

80.94

2.3

142.14

152.99

nmol/l

0.76

211

437

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1612

8601

1.73

80.42

3.3

3.1

6.05

6.33

umol/l

0.27

1321

7305

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2120

12171

1.63

80.02

3.1

2.6

1.01

0.96

e6/l

0.25

1027

5741

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1795

9904

1.68

79.04

2.0

1.8

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

282

709

3.52

78.45

1.9

1.7

1851559.78

1806981.62

iu/ml

0.02

(3007853) Bacteria identified in Skin by Aerobe culture

1780

9850

1.67

77.37

1.9

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1278

6504

1.80

74.75

3.0

3.7

4.72

4.73

pmol/l

0.08

1150

5975

(3022313) Gas panel - Capillary blood

744

3156

2.12

74.29

8.6

5.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

306

859

3.16

71.55

2.0

1.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1183

5971

1.80

70.94

1.2

33.69

12.24

u/ml

0.32

(3021387) Prolactin [Units/volume] in Serum or Plasma

1629

9032

1.66

69.69

1.7

1.6

362.14

302.73

mu/l

5.53

1429

8140

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4360

29869

1.42

68.82

1.9

1.7

1.47

1.34

mmol/l

11.42

3827

27097

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

892

4208

1.91

66.05

3.2

3.5

1.22

mmol/l

0.02

747

3628

(3020779) Urea [Moles/volume] in Serum or Plasma

1011

4969

1.84

65.91

11.1

9.5

6.26

6.60

mmol/l

1.29

981

4808

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3060

19783

1.46

65.24

2.6

2.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3534

23483

1.44

65.12

2.9

2.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

665

2843

2.10

64.90

9.1

5.5

24.09

24.25

mmol/l

1.06

649

2747

(3017143) Hepatitis C virus Ab [Presence] in Serum

3147

20523

1.45

63.87

2.0

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

833

3889

1.93

63.56

5.7

4.8

71.71

73.92

ng/l

0.31

758

3608

(40768797) Stomach Pathology biopsy report

1549

8677

1.64

63.18

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

307

932

2.92

62.74

1.8

1.6

1.29

1.38

promille

0.47

236

734

(3042936) Bacteria identified in Isolate by Culture

1674

9607

1.60

61.75

2.0

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1273

6851

1.69

60.43

2.0

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1242

6667

1.69

59.48

2.0

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

612

2621

2.09

59.38

9.5

6.1

9.46

9.43

kpa

0.18

589

2554

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1529

8665

1.61

59.24

2.7

2.2

11.31

11.77

nmol/l

1.12

1362

8074

(3027945) Reticulocytes/Erythrocytes in Blood

1118

5882

1.72

57.54

3.7

3.6

1.59

1.63

0.72

995

5393

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2861

18632

1.44

57.40

2.4

2.0

0.91

0.97

mg/l

0.36

1960

13354

(3015235) Bicarbonate [Moles/volume] in Capillary blood

473

1870

2.25

56.08

3.3

3.7

24.07

23.95

mmol/l

0.32

465

1830

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2162

13390

1.49

55.97

2.8

2.5

6582.22

7135.61

u/l

0.29

694

5583

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

104

155

5.89

55.02

1.2

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

465

1848

2.24

54.43

2.8

2.4

382.38

344.40

ug/l

0.15

413

1675

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1597

9362

1.56

53.14

3.9

3.0

760.21

655.45

ng/l

0.34

1160

7176

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

657

3018

1.95

52.38

1.8

1.5

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

356

1292

2.44

51.26

3.0

2.8

24.25

23.11

nmol/l

0.95

338

1256

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1099

5943

1.67

50.82

4.5

4.0

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1524

8938

1.56

50.42

2.4

2.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1678

10085

1.52

49.58

1.3

108.88

145.03

u/ml

3.35

580

3879

(21494755) Public health laboratory ask at order entry panel

1164

15337

0.63

48.51

1.2

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

344

1265

2.41

48.13

2.7

3.1

32.72

33.33

umol/l

0.20

318

1182

(3011397) Hemoglobin [Presence] in Urine by Test strip

3100

21020

1.38

47.78

3.6

3.2

0.18

0.30

0.34

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

10178

82550

1.45

47.71

19.3

12.7

13.19

13.15

4.11

10073

81427

(3029937) Albumin [Presence] in Urine by Test strip

3625

25217

1.36

47.54

3.8

3.3

0.00

0.01

estimate

0.70

1431

9781

(3012501) Base excess in Blood by calculation

344

1274

2.39

47.39

3.5

3.4

1.99

mmol/l

0.01

207

715

(3035350) Ketones [Presence] in Urine by Test strip

6406

48478

1.32

46.79

3.9

3.2

5.47

3.71

estimate

0.34

1476

10123

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1031

5616

1.66

46.18

3.3

2.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1243

7104

1.58

45.76

2.4

2.8

10.07

10.49

g/l

4.66

1147

6636

(3002179) Metamyelocytes/Leukocytes in Blood

1122

6264

1.62

45.54

4.6

0.39

0.54

1.63

286

1598

(3017181) Myelocytes/Leukocytes in Blood

1159

6522

1.61

45.53

5.1

4.8

0.62

0.80

1.39

300

1661

(3009261) Glucose [Presence] in Urine by Test strip

6416

48671

1.31

45.46

3.9

3.3

0.04

0.01

estimate

0.49

1442

9930

(1616796) Gas panel - Central venous blood

361

1391

2.30

45.46

3.4

3.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

6333

48005

1.31

44.85

3.8

3.2

0.00

estimate

0.36

1491

10202

(3021440) Promyelocytes/Leukocytes in Blood

1119

6286

1.61

44.22

5.2

4.9

0.06

0.12

1.94

262

1426

(3003396) Base excess in Arterial blood by calculation

953

5153

1.66

43.85

10.3

9.0

0.55

0.37

mmol/l

0.71

743

4052

(3019977) pH of Arterial blood

963

5225

1.66

43.72

10.3

9.1

7.41

7.42

0.44

491

2769

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

958

5196

1.66

43.55

10.2

9.0

5.09

5.00

kpa

2.10

926

4999

(3027801) Oxygen [Partial pressure] in Arterial blood

957

5196

1.66

43.32

10.2

9.0

13.07

14.19

kpa

7.47

925

5002

(3016502) Oxygen saturation in Arterial blood

857

4531

1.70

42.89

11.0

9.7

95.87

96.47

1.47

832

4363

(3023520) Reticulocytes [#/volume] in Blood

777

4008

1.74

42.52

3.1

3.3

69.91

71.03

e9/l

0.30

515

2721

(3025159) Blasts/Leukocytes in Blood

1136

6469

1.58

42.32

5.4

5.1

0.02

0.24

1.56

237

1391

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1363

8118

1.52

41.50

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1545

9469

1.48

40.92

4.0

2.7

29.55

29.27

1.11

1503

9197

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1109

6352

1.57

40.21

2.3

16.54

17.95

au/ml

0.36

118

907

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

10047

81864

1.39

40.16

4.3

3.5

2.81

mmol/l

0.02

9595

78888

(3002173) Hemoglobin [Mass/volume] in Arterial blood

814

4334

1.68

39.61

10.4

9.9

126.20

124.20

g/l

1.94

798

4234

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

692

3530

1.75

39.33

1.5

—

(3007463) Buprenorphine [Presence] in Urine

6.19

39.05

7.6

6.1

—

(3007461) Platelets [#/volume] in Blood

11987

101822

2.45

39.02

24.1

15.8

268.94

262.08

e9/l

29.56

11810

100006

(3028026) IgM [Mass/volume] in Serum or Plasma

980

5498

1.60

38.75

1.6

1.8

1.23

g/l

0.06

921

5181

(3036180) Methadone [Presence] in Urine

10.02

38.70

2.5

3.1

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

11988

101881

2.43

38.03

23.9

15.7

89.03

89.11

1.34

11916

101171

(3035941) MCH [Entitic mass]

11989

101894

2.44

38.01

23.9

15.7

29.82

29.88

3.19

11917

101187

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

11989

101900

2.43

37.88

24.6

16.1

40.99

41.72

3.55

11915

101141

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1700

19898

0.70

37.61

1.5

1.6

1017.21

1011.77

mu/l

0.07

1408

17400

(3010813) Leukocytes [#/volume] in Blood

11991

101941

2.43

37.53

24.1

15.8

6.96

6.78

e9/l

14.77

11789

99971

(3026361) Erythrocytes [#/volume] in Blood

11988

101908

2.42

37.46

24.0

15.8

4.63

4.61

e12/l

5.42

11784

99954

(3004119) Hemoglobin [Mass/volume] in Venous blood

646

3279

1.76

37.33

4.6

4.7

133.50

134.20

g/l

0.35

624

3211

(3015171) Extractable nuclear Ab [Units/volume] in Serum

682

3519

1.73

37.20

1.2

1.3

0.88

0.95

u/ml

0.04

228

(3020682) Albumin/Creatinine [Ratio] in Urine

2096

13805

1.39

37.12

4.5

4.7

13.14

13.21

mg/mmol

0.01

1442

9632

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

548

2658

1.83

36.86

1.8

1.6

411.43

386.57

mu/l

0.41

445

2204

(3005322) IgE [Units/volume] in Serum or Plasma

1326

8045

1.49

36.68

1.4

1.3

340.46

262.80

u/ml

0.52

1221

7482

(3000963) Hemoglobin [Mass/volume] in Blood

11989

101959

2.40

36.64

24.2

15.9

137.42

137.12

g/l

1.71

11917

101264

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1037

5985

1.56

36.22

1.3

30.57

39.25

au/ml

0.82

291

(3000570) Elastase.pancreatic [Mass/mass] in Stool

395

1727

2.03

36.18

1.4

1.3

314.79

319.12

ug/g

0.13

181

840

(3012516) Albumin [Mass/volume] in Urine

2065

13642

1.38

35.77

3.8

4.0

91.65

75.12

mg/l

0.73

1461

9591

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1106

6536

1.52

34.62

3.3

2.9

30.93

31.69

1.47

854

5077

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

9980

81694

1.35

34.45

4.1

3.4

4.58

4.65

mmol/l

13.12

9572

79065

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

570

2860

1.77

34.25

2.0

5.56

7.66

ug/l

1.19

498

2520

(3016650) Hepatitis A virus Ab [Presence] in Serum

435

2008

1.92

34.11

1.2

1.1

—

(3000494) Fungus identified in Specimen by Culture

1502

9469

1.44

33.89

1.6

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

515

2518

1.82

33.74

1.6

438.58

438.66

mg/l

0.00

495

2420

(3009214) Lutropin [Units/volume] in Serum or Plasma

1116

6646

1.51

33.65

1.6

1.5

7.03

7.92

u/l

2.46

840

5322

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1383

16504

0.70

33.65

1.6

3.56

3.47

ratio

1.64

973

11614

(3052851) Hemolysis interference index of Serum or Plasma

401

1810

1.96

33.58

2.6

4.39

2.44

index

1.13

235

1005

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

545

2726

1.78

33.10

14.2

11.8

24.02

23.91

mmol/l

0.37

531

2671

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

822

4588

1.60

33.06

1.6

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

852

4812

1.58

32.59

2.5

2.3

0.32

0.29

e6/l

0.13

813

4535

(3023323) Follitropin [Units/volume] in Serum or Plasma

1436

9043

1.43

32.51

1.6

1.5

12.21

15.35

iu/l

6.82

1147

7493

(3024928) Oxygen saturation in Venous blood

363

1601

2.01

32.47

5.2

5.3

64.65

65.28

0.22

343

1558

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

845

4772

1.58

32.33

1.5

1.6

3.93

3.96

mg/l

0.03

678

3161

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

466

2243

1.84

32.12

1.5

3.58

3.53

mmol/l

0.52

444

2126

(3016244) Insulin [Units/volume] in Serum or Plasma

299

1237

2.13

31.74

3.0

3.1

29.85

25.00

mu/l

0.95

280

1161

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1046

12988

0.67

31.31

1.5

1.4

3.40

3.39

mmol/l

0.03

666

8200

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

9908

81294

1.33

31.25

4.0

3.3

1.36

1.43

mmol/l

76.03

9464

78446

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

466

2264

1.83

31.17

1.7

8574.16

1008.03

e6/l

0.44

359

1755

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

865

4969

1.56

30.70

1.5

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

410

1923

1.89

30.65

1.2

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

459

2233

1.82

30.57

1.7

16.83

19.34

e6/l

0.24

335

1638

(3044290) Cell count panel - Cerebral spinal fluid

441

2126

1.84

30.25

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

554

2891

1.70

28.95

11.0

7.4

1.19

1.18

mg/l

0.27

531

2756

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

9271

75606

1.29

28.85

3.5

3.0

1.29

1.20

mmol/l

19.80

8814

72877

(3048929) Epstein Barr virus Ab [Presence] in Serum

1168

7251

1.45

28.35

1.5

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

534

2777

1.71

28.26

13.1

11.0

16.50

16.46

0.12

519

2673

(3013139) Helicobacter pylori Ag [Presence] in Stool

1007

6088

1.48

28.02

1.2

—

(3017732) Neutrophils [#/volume] in Blood

1576

10358

1.37

27.52

3.6

2.7

4.29

4.43

e9/l

0.73

1359

9425

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

451

2277

1.75

26.53

4.1

4.5

54.39

50.42

2.70

437

2242

(3007566) Smooth muscle Ab [Titer] in Serum

502

2616

1.70

26.37

1.3

1.4

77.05

97.12

titre

0.87

278

(3017509) Phencyclidine [Presence] in Urine

100

262

3.35

26.37

2.5

1.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

456

2315

1.74

26.32

1.2

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

586

3194

1.63

25.91

1.4

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

542

2901

1.66

25.74

2.3

1.8

192.99

197.18

pmol/l

0.29

523

2791

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

327

1511

1.91

25.62

1.4

1.3

—

(3021901) Oxygen saturation in Capillary blood

267

1157

2.03

25.15

2.9

3.3

93.06

92.77

0.39

258

1125

(3013005) Retinol [Moles/volume] in Serum or Plasma

175

639

2.41

25.05

2.7

2.8

1.78

1.79

umol/l

0.06

163

594

(3020961) Endomysium IgA Ab [Titer] in Serum

1099

6898

1.43

25.01

1.2

207.08

181.90

titre

0.13

229

(3022145) Colonoscopy Study observation

1243

7994

1.40

24.59

1.4

1.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

770

4535

1.51

24.27

2.1

1.7

38.79

39.76

nmol/l

0.38

754

4481

(40761536) Microorganisms panel - Urine sediment

1244

8038

1.39

23.90

3.7

3.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1105

12928

0.72

22.96

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

5743

45077

1.21

22.23

2.8

2.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2258

16078

1.27

21.85

2.5

2.3

311.49

317.32

umol/l

2.10

1997

14981

(3008898) HLA-B27 [Presence]

868

5364

1.44

21.42

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

538

3021

1.58

21.03

1.8

2.0

0.22

0.23

g/l

1.35

517

2909

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

429

5923

0.62

20.78

1.0

1.1

0.64

0.63

ratio

0.08

440

(3008152) Bicarbonate [Moles/volume] in Arterial blood

479

2626

1.61

20.71

5.9

6.8

24.04

24.01

mmol/l

0.06

461

2500

(3029634) Reagin Ab [Titer] in Serum by VDRL

455

2463

1.63

20.70

2.0

2.1

6.40

9.70

titre

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4788

37116

1.20

20.56

3.6

3.0

0.42

0.09

estimate

0.37

1234

8695

(3027273) Bicarbonate [Moles/volume] in Venous blood

398

2095

1.68

20.19

4.0

4.2

24.98

24.89

mmol/l

0.22

383

2012

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

138

3.87

20.02

4.3

4.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

544

3099

1.55

19.97

1.8

2.0

1.18

1.17

g/l

0.16

527

2987

(3008295) Osmolality of Serum or Plasma

179

729

2.16

19.94

1.9

2.0

288.40

287.13

mosm/kgh2o

0.47

141

563

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

194

819

2.08

19.71

3.9

2.7

96.83

97.90

0.17

184

755

(3023420) DNA double strand Ab [Units/volume] in Serum

656

3902

1.49

19.69

1.9

2.1

7.74

7.49

iu/ml

0.05

137

929

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

273

1302

1.85

19.50

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

273

1303

1.84

19.45

1.3

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

650

3870

1.49

19.42

1.6

1.7

6.61

8.60

u/ml

1.05

150

1213

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

457

6126

0.64

19.40

1.1

1.48

1.49

g/l

0.67

457

6118

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

108

357

2.65

19.11

1.8

1.9

0.19

0.21

nmol/l

0.26

279

(3037121) Protein [Mass/volume] in Urine

455

2514

1.60

19.06

3.8

4.0

598.34

411.72

mg/l

0.27

249

1389

(3034770) Mitochondria Ab [Titer] in Serum

455

2524

1.59

18.75

1.3

1.4

286.67

1155.83

titre

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

4.57

18.72

1.0

1.1

46.15

49.50

mg/l

0.30

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

609

3606

1.50

18.69

1.7

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

480

2699

1.57

18.67

1.2

1.3

48.68

35.64

u/ml

0.24

156

(3020630) Protein [Mass/volume] in Serum or Plasma

548

3174

1.53

18.67

1.8

2.2

67.00

67.71

g/l

1.49

511

3030

(3023410) Appearance of Cerebral spinal fluid

242

1127

1.89

18.63

2.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

576

3382

1.51

18.41

1.5

1.4

233.26

219.02

u/ml

0.64

341

2086

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

385

2059

1.65

18.41

1.8

2647.27

3665.35

titre

0.43

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

601

3574

1.49

18.06

1.5

1.3

71.46

36.18

u/ml

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

934

10788

0.73

17.54

1.5

62.74

62.79

ug/l

0.01

764

9252

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

292

1471

1.75

17.43

1.3

6.32

6.42

umol/l

0.16

260

1343

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

447

2513

1.57

17.42

1.2

1.3

9.24

8.13

u/ml

0.06

223

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

192

852

1.98

17.08

1.2

23.14

31.08

nmol/l

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

465

2650

1.55

17.07

4.3

2.9

114.43

101.30

ng/l

0.32

396

2266

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

873

10139

0.73

16.97

1.4

1.5

1.20

1.16

ratio

0.46

520

6118

(3014765) Yersinia sp identified in Stool by Organism specific culture

467

2670

1.54

16.90

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

467

2670

1.54

16.90

1.2

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

133

514

2.27

16.90

1.5

1.6

2.54

2.59

nmol/l

0.01

102

402

(42529406) Shigella sp [Presence] in Stool by Culture

469

2690

1.54

16.74

1.2

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

878

10166

0.73

16.71

1.4

1.5

1.22

1.18

ratio

0.73

529

6203

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

878

10166

0.73

16.71

1.5

0.94

0.95

ratio

0.18

525

6146

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

441

2498

1.56

16.64

2.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

444

2519

1.56

16.64

1.3

14.75

13.91

u/ml

0.05

327

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

198

899

1.93

16.50

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

152

627

2.13

16.48

9.5

6.7

9.12

9.86

mg/l

1.35

147

577

(3006653) Thiamine [Moles/volume] in Blood

101

349

2.53

16.42

1.4

130.54

134.98

nmol/l

0.51

101

349

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

128

495

2.27

16.26

3.1

3.2

25.91

26.08

umol/l

0.07

121

466

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

858

9926

0.73

16.22

1.4

1.5

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

131

513

2.24

16.16

2.8

3.1

1.61

1.31

ug/l

0.69

125

484

(44813793) Dust mix specific IgE antibody measurement

207

962

1.89

16.11

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

397

2212

1.58

16.10

1.2

1.3

35.57

42.29

u/ml

0.24

170

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

635

7697

0.70

16.02

1.5

60.31

59.99

ug/l

0.06

635

7697

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

279

1434

1.71

15.55

2.0

2.78

1.77

ug/l

0.72

249

1277

(3045414) Leukocytes [Presence] in Urine

1057

7102

1.33

15.53

2.0

1.8

0.03

0.04

estimate

0.28

277

1853

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2705

20308

1.21

15.28

2.5

2.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

481

6075

0.68

15.21

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

134

545

2.16

15.10

3.4

3.3

17.05

15.39

index

0.65

107

413

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

291

1530

1.67

14.93

2.6

3.3

0.88

0.83

nmol/l

0.48

255

1332

(1002224) Polysomnography panel

799

5178

1.37

14.91

1.1

—

(3003129) Base excess in Capillary blood by calculation

125

502

2.18

14.55

2.2

1.9

0.35

0.40

mmol/l

0.06

108

446

(3047181) Lactate [Moles/volume] in Blood

308

1657

1.64

14.47

4.4

5.3

1.26

1.20

mmol/l

0.57

275

1465

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

508

3056

1.47

14.45

2.1

2.3

2.84

3.57

iu/l

2.42

215

1383

(3047352) Trisomy 18 risk [Likelihood] in Fetus

712

8317

0.73

14.27

1.5

—

(3003181) Sodium [Moles/volume] in Urine

161

717

1.97

14.26

1.8

2.2

67.39

74.49

mmol/l

0.87

125

601

(3024522) Salmonella sp identified in Specimen by Organism specific culture

186

874

1.87

14.05

1.3

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

394

2266

1.53

13.94

2.0

1.9

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

6.69

13.89

3.0

2.5

2.63

2.49

ug/l

0.08

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

715

4612

1.37

13.74

1.2

2.48

2.91

u/ml

0.47

421

2598

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

188

895

1.84

13.65

1.3

1.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.57

13.53

1.7

2.3

215.83

260.61

ug/l

0.88

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

178

836

1.87

13.49

1.3

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

646

4111

1.39

13.48

1.1

6.16

7.27

u/ml

0.91

392

2485

(3005988) Vibrio sp identified in Specimen by Organism specific culture

178

837

1.87

13.44

1.3

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

833

9426

0.75

13.42

1.6

1.7

—

(3005033) Fetal Nuchal fold Thickness US

697

8091

0.74

13.39

1.5

1.26

0.05

480

6121

(3025468) Yersinia sp identified in Specimen by Organism specific culture

177

832

1.87

13.38

1.3

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

410

2402

1.50

13.32

1.4

12.70

14.26

u/l

0.66

317

2035

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

718

4662

1.36

13.24

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

734

8436

0.74

13.18

1.5

1.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

142

623

2.00

13.16

1.2

1.1

59.87

14.56

u/ml

0.39

100

430

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.92

13.16

5.8

5.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

100

383

2.29

13.09

1.3

1.4

87.21

91.86

nmol/24h

0.21

100

383

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

120

3.42

13.09

1.3

1.2

1.18

mmol/l

0.24

120

(3036489) Thrombin time

603

3813

1.40

13.08

4.0

2.7

20.52

0.01

529

3272

(3010726) Horse dander IgE Ab [Units/volume] in Serum

634

4045

1.39

13.04

1.1

2.51

2.68

u/ml

0.16

379

2236

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

183

877

1.83

13.03

1.3

1.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

158

723

1.92

12.98

1.3

1.4

9.94

10.61

umol/l

0.80

149

687

(4062490) Immunoglobulin typing, IgG

211

1058

1.75

12.92

1.3

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

238

2.65

12.89

1.3

1.4

150.28

120.82

nmol/l

0.34

181

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

166

774

1.88

12.89

1.2

1.3

1.73

1.75

mmol/l

0.13

152

726

(3027135) IgG subclass 1 [Mass/volume] in Serum

212

1066

1.75

12.86

1.3

6.21

6.61

g/l

1.42

165

772

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.37

12.80

8.4

7.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

893

6023

1.32

12.74

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

145

651

1.95

12.61

2.5

2.3

26.01

25.23

mg/l

0.09

459

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.78

12.58

6.3

5.1

72650.00

424643.27

u/ml

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

155

716

1.90

12.40

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

210

1065

1.73

12.38

1.3

0.35

0.38

g/l

0.77

162

768

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

528

3296

1.41

12.35

4.1

3.1

160.16

165.66

0.89

499

3143

(3028192) IgG subclass 2 [Mass/volume] in Serum

210

1066

1.73

12.34

1.3

2.69

2.97

g/l

1.89

163

773

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

349

2010

1.53

12.32

1.2

1.3

12.27

4.47

u/ml

—

121

(3008401) Mugwort IgE Ab [Units/volume] in Serum

613

3929

1.38

12.27

1.1

1.84

1.14

u/ml

0.86

331

1963

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

147

670

1.92

12.25

1.2

1.1

115.72

120.23

pmol/l

0.55

147

670

(3014051) Protein [Presence] in Urine by Test strip

3641

28494

1.16

12.05

2.9

2.5

0.04

0.06

253

(3020393) Adenovirus Ag [Presence] in Stool

207

2.70

11.98

2.1

1.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

120

515

2.04

11.87

1.8

1.9

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

212

1092

1.70

11.84

1.8

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

480

2975

1.42

11.70

1.7

1.5

13.24

21.05

u/ml

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

6.11

11.68

1.3

119.07

101.96

nmol/l

0.19

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

115

489

2.06

11.67

1.1

14.74

16.08

u/ml

0.10

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

341

1982

1.51

11.56

4.3

5.3

2.06

1.71

3.24

319

1867

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

344

2.26

11.47

1.4

1.5

12.88

13.80

pmol/l

1.10

301

(3006184) Hemoglobin [Mass/volume] in Capillary blood

281

1568

1.57

11.45

2.0

2.2

136.61

135.10

g/l

0.61

248

1333

(3025941) Bacteria identified in Stool by Culture

906

6219

1.29

11.34

1.3

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

194

991

1.72

11.19

1.2

1.3

0.48

2.24

nmol/l

0.50

187

963

(3027231) Wheat IgE Ab [Units/volume] in Serum

110

469

2.05

11.10

1.1

0.75

5.75

u/ml

1.61

427

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

459

2852

1.42

11.05

1.7

1.5

121.07

137.42

au/ml

2.01

140

766

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

164

802

1.79

11.01

1.1

282.04

281.87

mg/l

0.01

152

753

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

4.53

10.99

1.5

469.59

528.45

nmol/l

0.20

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

171

848

1.77

10.96

1.3

1.4

553.22

473.49

mu/l

0.82

161

810

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

477

2993

1.40

10.87

1.7

1.5

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

150

2.91

10.78

6.4

1.88

2.45

mg/l

1.62

135

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

120

534

1.97

10.78

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

165

816

1.77

10.68

1.2

1.3

0.17

0.18

nmol/l

0.16

128

595

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

216

2.55

10.57

3.4

2.2

—

(3049233) Organic acids panel - Urine

4.21

10.44

1.1

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

146

702

1.82

10.39

1.7

1.9

17.52

21.32

umol/l

1.29

137

665

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

188

973

1.69

10.38

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

951

6645

1.27

10.32

4.4

4.3

226.73

228.81

u/l

0.14

896

6383

(3011985) Renin [Units/volume] in Plasma

202

1068

1.66

10.30

1.8

2.0

54.94

71.03

mu/l

0.67

184

984

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

192

1002

1.68

10.28

1.2

1.3

0.20

0.26

nmol/l

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

188

976

1.69

10.27

1.5

439.98

527.05

pmol/l

0.35

161

852

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

173

878

1.73

10.26

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5135

41513

1.13

10.10

2.9

2.7

—

estimate

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

281

1615

1.53

10.09

1.2

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

171

870

1.72

10.06

1.3

1.4

75.01

73.16

1.29

161

832

(3004809) Band form neutrophils/Leukocytes in Blood

177

910

1.71

10.03

2.7

3.0

1.28

1.32

0.06

154

829

(3013336) Amino acids [Identifier] in Serum or Plasma

101

3.29

10.03

2.3

2.5

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

223

1218

1.61

10.00

1.0

1.1

—

22.14

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1085

7727

1.25

9.99

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

203

1085

1.64

9.94

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

177

913

1.70

9.92

1.9

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

293

1707

1.51

9.89

1.5

1.7

0.63

0.72

g/l

0.96

236

1354

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

548

3576

1.35

9.85

1.6

0.33

0.45

nmol/l

3.90

448

2985

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

310

1831

1.49

9.79

1.3

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

220

1205

1.60

9.77

3.6

3.9

6.63

7.43

pmol/l

0.62

220

1205

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

225

1240

1.59

9.74

1.0

1.1

—

26.00

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

182

952

1.68

9.69

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

436

5169

0.73

9.60

1.3

3.83

3.68

ug/l

0.18

412

4941

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

108

484

1.95

9.56

1.1

0.15

4.08

nmol/l

1.46

(3004588) Protein electrophoresis panel - Serum or Plasma

350

2132

1.44

9.45

1.6

1.7

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

416

2619

1.40

9.35

1.3

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

554

3651

1.34

9.34

1.1

4.35

4.23

eliau/ml

0.03

584

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

543

3568

1.34

9.34

6.8

3.1

96.46

95.64

0.39

518

3446

(3010015) Selenium [Moles/volume] in Serum or Plasma

168

2.65

9.31

2.2

2.8

1.23

1.19

umol/l

0.33

138

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

166

857

1.70

9.30

1.1

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

165

852

1.70

9.24

1.1

1.2

—

(3045424) Erythrocytes [Presence] in Urine

568

3764

1.33

9.22

2.0

1.8

0.02

0.19

estimate

0.54

222

1540

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

516

3372

1.35

9.21

1.7

2.0

39.17

39.90

u/l

0.37

476

3204

(3041096) Erythrocytes [Presence] in Urine by Automated

3676

29217

1.14

9.18

3.1

2.6

0.01

0.07

estimate

1.23

1259

8616

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

287

1696

1.49

9.08

1.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

156

799

1.71

9.01

1.2

1.3

25.96

32.98

u/l

0.19

134

701

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

210

1163

1.58

8.94

1.2

42.21

38.24

mg/l

0.21

169

982

(3019420) Tryptase [Mass/volume] in Serum or Plasma

148

750

1.73

8.89

1.8

1.5

7.67

6.00

ug/l

0.31

131

672

(43055514) Macroprolactin [Presence] in Serum or Plasma

136

673

1.77

8.87

1.2

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

168

883

1.67

8.83

1.8

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

162

847

1.68

8.69

2.6

—

(3002256) Pathology report gross observation

1244

9116

1.21

8.68

1.2

—

(3032641) Amino acids panel - Urine

4.36

8.59

1.1

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

294

1770

1.46

8.49

1.8

1.7

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

4.88

8.43

1.4

1.9

145.43

306.00

nmol/l

0.82

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

166

882

1.65

8.39

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

447

2902

1.36

8.36

1.1

1.01

0.30

u/ml

0.73

168

925

(3026250) Tacrolimus [Mass/volume] in Blood

104

484

1.88

8.30

57.1

45.1

7.29

ug/l

0.01

456

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

166

885

1.64

8.29

1.2

—

(3042733) HLA Ab [Presence] in Serum

340

2.06

8.26

4.8

4.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

521

3469

1.32

8.22

1.1

5.32

5.05

u/ml

0.12

293

1937

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

160

847

1.65

8.22

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

158

834

1.66

8.21

1.1

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

505

3349

1.33

8.20

1.2

4.47

4.96

0.43

578

(3023430) Cat dander IgE Ab [Units/volume] in Serum

492

3255

1.33

8.12

1.1

8.81

6.71

u/ml

0.82

252

1640

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

262

2.20

8.11

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

165

885

1.63

8.06

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

162

865

1.64

8.06

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

192

2.41

8.03

2.0

2.9

30.12

29.11

umol/l

0.19

138

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

201

1133

1.56

7.98

1.1

247.74

219.52

mg/l

0.24

175

1009

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

167

903

1.62

7.91

1.2

—

(3002619) Bacteria identified in Specimen by Culture

215

2.32

7.90

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

302

1854

1.43

7.90

1.1

1.2

94.04

5515.78

iu/ml

0.64

493

(3024471) HLA-A [Type]

300

2.10

7.86

1.1

1.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

162

871

1.63

7.85

2.6

2.9

189.29

214.61

e6/l

1.15

123

670

(3009445) Proteinase 3 Ab [Units/volume] in Serum

443

2905

1.34

7.78

1.4

1.7

3.95

10.71

iu/ml

2.27

118

(3000034) Microalbumin [Mass/volume] in Urine

385

1.95

7.73

2.9

3.2

134.04

89.90

mg/l

0.26

288

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

110

534

1.80

7.71

1.2

9.92

10.39

u/ml

0.03

366

(3008757) Leukocyte morphology finding [Identifier] in Blood

124

624

1.74

7.70

2.6

3.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

293

1800

1.43

7.65

4.6

5.6

0.86

0.93

1.98

273

1695

(3011412) CD3 cells [#/volume] in Blood

187

1049

1.56

7.61

2.5

2.8

1503.53

1380.12

e6/l

0.81

148

851

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

258

1553

1.46

7.51

7.7

4.2

380.61

838.62

u/ml

0.91

(3017354) Segmented neutrophils/Leukocytes in Blood

111

545

1.78

7.51

2.4

2.8

54.54

53.54

0.22

477

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

120

603

1.74

7.50

1.5

1.4

1.66

1.36

nmol/l

1.84

104

552

(3024932) HLA-DR beta [Type]

297

2.06

7.31

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

515

3483

1.30

7.30

5.4

3.2

3.36

3.48

g/l

1.19

485

3320

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

191

1088

1.54

7.28

1.2

402.27

385.81

titre

0.02

(4027681) Cerebrospinal fluid IgG ratio and IgG index

168

931

1.58

7.23

1.3

1.2

0.72

0.69

ratio

0.18

534

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

352

1.96

7.22

1.1

54.50

123.27

ng/l

0.59

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

124

2.68

7.15

1.6

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

204

1185

1.51

7.11

1.1

1.2

12.23

34.39

u/ml

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

118

602

1.71

7.02

2.7

2.5

26.14

28.26

1.10

118

589

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

102

500

1.78

6.97

1.8

138.63

133.62

0.26

469

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

223

2.19

6.89

8.3

7.4

1177.50

3002.16

iu/ml

—

(4024509) Urine culture

488

3306

1.30

6.85

2.1

1.7

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

306

2.00

6.78

1.2

1.1

3.58

3.85

u/ml

0.06

240

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

154

850

1.59

6.77

2.6

2.8

519.68

558.18

e6/l

0.55

115

634

(1175426) CD3 cells/Lymphocytes in Blood

162

905

1.57

6.77

2.6

2.5

71.29

73.76

0.84

162

885

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

158

878

1.58

6.75

2.6

2.5

10.61

12.05

1.09

158

864

(3045716) Anion gap in Serum or Plasma by calculation

105

526

1.75

6.69

2.2

3.1

10.27

10.71

mmol/l

0.54

518

(3026389) Candida sp identified in Specimen by Organism specific culture

261

1612

1.42

6.67

1.2

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

187

1083

1.51

6.65

1.6

1.4

71.71

76.19

0.30

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

210

1246

1.48

6.64

1.1

1.41

1.43

g/l

0.50

195

1160

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

10029

85305

1.14

6.61

19.4

12.7

334.17

334.28

g/l

0.60

9995

84728

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

205

2.22

6.58

2.0

1.9

7.56

3.48

nmol/l

0.52

197

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

316

2024

1.37

6.53

8.3

6.2

525.97

650.35

iu/ml

0.27

218

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

101

505

1.75

6.49

1.2

113.77

109.12

0.48

451

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

184

2.28

6.49

3.7

5.2

5.20

4.80

kpa

1.94

184

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

184

2.28

6.49

3.7

5.2

12.01

11.06

kpa

0.69

184

(3001186) Copper [Moles/volume] in Serum or Plasma

326

1.93

6.34

1.3

1.6

17.30

16.25

umol/l

0.74

282

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

297

1893

1.38

6.34

1.9

1.7

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

106

542

1.71

6.31

1.7

1.4

5.03

6.05

nmol/l

2.36

100

519

(3020874) Milk IgE Ab [Units/volume] in Serum

224

1366

1.44

6.17

1.2

1.1

3.43

3.26

u/ml

0.03

107

527

(3000060) B lymphocytes [#/volume] in Blood

111

579

1.68

6.15

2.9

2.6

0.27

0.26

e9/l

0.03

281

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

585

4110

1.25

6.15

1.4

1.3

—

(3016031) Almond IgE Ab [Units/volume] in Serum

206

2.16

6.11

1.1

0.83

1.24

u/ml

0.53

142

(3002079) Sodium [Moles/time] in 24 hour Urine

419

1.79

6.06

1.5

1.4

167.32

163.18

mmol/24h

0.15

419

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

311

2014

1.35

6.03

1.4

1.5

17.02

5.94

iu/ml

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

213

2.13

6.02

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

478

1.74

6.00

1.2

1.1

91.26

97.46

0.84

216

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

491

1.73

6.00

1.2

1.1

94.38

97.08

0.54

217

(3010838) Calcium [Moles/time] in 24 hour Urine

181

1066

1.49

5.98

1.9

2.0

5.34

5.26

mmol/24h

0.12

164

998

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

473

1.74

5.94

1.5

1.6

5.20

5.77

u/l

0.68

400

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

178

1048

1.49

5.90

1.5

1.6

—

titre

—

(3010375) cycloSPORINE [Mass/volume] in Blood

404

1.80

5.88

37.0

28.8

137.11

122.06

ug/l

0.77

337

(3006270) Folate [Moles/volume] in Blood

436

1.76

5.87

1.1

427.44

415.29

nmol/l

0.22

417

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

501

1.71

5.87

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

483

1.72

5.80

3.4

2.9

57.42

51.33

umol/l

1.15

456

(3040151) Glucose [Moles/volume] in Capillary blood

145

821

1.55

5.78

2.7

4.0

6.99

6.88

mmol/l

0.11

117

683

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

211

2.11

5.77

1.1

0.90

0.56

u/ml

0.21

211

(3027923) C peptide [Moles/volume] in Serum or Plasma

350

1.85

5.75

2.0

2.3

1.57

1.36

nmol/l

0.64

282

(3004616) Nuclear Ab [Presence] in Serum

162

942

1.51

5.72

1.4

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

137

775

1.55

5.50

1.6

1.7

—

(37208534) Antinuclear antibody arbitrary concentration in serum

388

1.78

5.46

1.0

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

153

889

1.51

5.44

1.2

4.80

4.37

u/ml

0.14

529

(3018133) Calcium [Moles/volume] in Urine

332

1.84

5.42

2.1

3.3

2.77

2.61

mmol/l

0.30

312

(40768446) Kidney Pathology biopsy report

402

1.76

5.41

2.5

1.8

—

(3045462) Protein/Creatinine [Ratio] in Urine

321

1.85

5.35

5.8

6.1

64.42

215.64

mg/mmol

0.51

294

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

117

645

1.59

5.27

1.6

1.8

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

4.81

5.27

1.8

1.3

2.08

2.16

g/l

0.07

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

458

1.70

5.25

1.6

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

182

1105

1.44

5.21

1.4

1.7

0.39

0.32

g/l

0.17

162

1021

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

200

1236

1.42

5.20

1.4

1.6

2.69

2.83

g/l

1.48

188

1177

(4034850) Laboratory test

291

1913

1.33

5.17

10.0

6.7

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

507

1.66

5.15

1.3

66.25

77.29

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

190

1166

1.43

5.14

15.9

5.4

0.31

0.33

iu/ml

0.49

104

587

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

154

908

1.48

5.13

1.4

1.6

0.00

g/l

-0.00

141

869

(3041672) Baker's yeast Ab [Presence] in Serum

109

2.48

5.12

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

175

2.15

5.12

1.4

1.3

1.44

1.64

iu/ml

0.28

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

661

4805

1.21

5.08

2.3

2.4

85.27

85.36

ml/min/173m2

0.02

283

1833

(3022621) pH of Urine by Test strip

943

7077

1.17

5.06

2.4

2.1

6.21

6.28

1.38

607

4281

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

160

954

1.47

5.05

1.3

1.6

0.00

g/l

0.50

141

870

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

204

1273

1.40

5.03

1.4

1.6

3.48

3.67

g/l

1.69

192

1215

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

204

1274

1.40

5.01

1.4

1.6

4.24

4.28

g/l

0.37

191

1216

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

204

1275

1.40

4.99

1.4

1.6

7.07

7.04

g/l

0.12

192

1216

(3017950) Salicylates [Moles/volume] in Serum or Plasma

4.50

4.99

3.9

3.0

1727.00

1532.60

umol/l

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

304

1.84

4.97

1.2

1.1

87.00

87.27

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

526

1.63

4.95

1.3

1.2

110.85

71.94

u/l

0.74

470

(3000492) Spirometry study

1320

10178

1.15

4.94

1.4

—

20.35

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

305

1.83

4.92

1.2

1.1

63.14

78.12

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

148

874

1.48

4.91

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

474

1.66

4.90

1.4

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

474

1.66

4.90

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

474

1.66

4.90

1.4

1.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

376

1.74

4.88

1.7

1.5

26303.65

66009.25

e6/l

0.78

250

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

138

805

1.50

4.86

2.3

2.5

32.19

31.96

mg/l

0.02

115

677

(3034860) Kappa light chains.free [Mass/volume] in Serum

138

805

1.50

4.86

2.3

2.5

40.86

43.77

mg/l

0.12

116

677

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

300

1.83

4.86

1.2

1.3

—

(3007542) Rye IgE Ab [Units/volume] in Serum

112

2.42

4.86

1.0

0.34

17.94

u/ml

0.51

(3039000) Anion gap in Blood by calculation

160

962

1.46

4.85

6.2

7.4

11.80

11.52

mmol/l

0.46

147

868

(3016038) Potassium [Moles/volume] in Urine

364

1.75

4.84

1.9

2.4

36.20

34.60

mmol/l

0.20

347

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

403

1.71

4.84

1.5

—

(3018572) Chloride [Moles/volume] in Blood

160

963

1.45

4.83

6.2

7.4

105.35

105.63

mmol/l

0.31

147

869

(3044242) Glucose [Moles/volume] in Arterial blood

222

1.97

4.76

1.6

2.6

7.80

7.83

mmol/l

0.01

222

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

141

2.23

4.72

1.4

1.8

17.92

16.51

nmol/l

0.27

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

304

1.81

4.68

1.2

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.82

4.66

1.0

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

317

1.79

4.66

1.3

1.2

75.58

103.62

u/l

0.80

269

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

311

1.80

4.65

1.3

1.2

13.33

21.20

u/l

0.79

262

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

168

1030

1.43

4.61

1.3

1.6

0.01

g/l

0.12

152

966

(3011841) English Walnut IgE Ab [Units/volume] in Serum

312

1.79

4.60

1.2

1.1

5.61

5.41

u/ml

0.02

251

(3015076) Soybean IgE Ab [Units/volume] in Serum

198

1251

1.39

4.58

1.1

2.52

0.97

u/ml

0.43

389

(4146454) Self-monitoring of blood glucose

313

1.79

4.56

3.3

3.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.78

4.55

2.5

2.0

—

(3000330) Specific gravity of Urine by Test strip

434

3059

1.25

4.53

2.7

2.5

1.02

ratio

0.31

373

2646

(3006442) Creatine [Moles/volume] in Serum or Plasma

514

1.60

4.45

1.4

1.3

73.12

74.44

umol/l

0.08

514

(3022493) Free Hemoglobin [Mass/volume] in Plasma

371

1.70

4.30

10.7

4.1

2600.47

3006.43

mg/l

0.05

278

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

467

1.61

4.21

1.3

1.2

0.28

0.29

g/l

0.47

378

(3014599) Egg white IgE Ab [Units/volume] in Serum

208

1346

1.35

4.19

1.2

1.1

2.81

7.24

u/ml

0.76

439

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

271

1.80

4.16

2.4

2.5

1.47

1.73

mmol/l

0.27

206

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

176

1111

1.39

4.14

1.4

1.6

9.67

10.45

g/l

2.29

163

1050

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.86

4.14

1.7

1.5

12.42

8.63

pmol/l

0.28

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

208

1351

1.35

4.10

1.2

1.23

1.03

0.14

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

133

2.17

4.09

1.3

1.7

20.46

33.24

ng/l

0.40

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

188

1204

1.37

4.06

2.2

2.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

217

1.89

4.05

1.1

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

217

1.89

4.05

1.1

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4371

36195

1.08

4.05

2.0

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

293

1.76

4.04

1.4

2.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

242

2735

0.77

4.03

1.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

365

2560

1.25

4.03

1.2

1.1

19.79

16.23

au/ml

0.30

785

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

275

1.78

3.98

1.1

2.50

1.51

u/ml

0.35

194

(3028679) Herpes simplex virus Ab [Presence] in Serum

165

1038

1.39

3.98

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

119

705

1.48

3.97

1.1

1.0

13.94

14.18

u/ml

0.03

490

(3033942) Copper [Moles/time] in 24 hour Urine

2.51

3.94

1.1

1.5

0.30

1.16

umol/24h

—

(3001556) Androgen free Index in Serum or Plasma

302

1.73

3.93

1.3

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

104

602

1.51

3.89

2.3

1.7

20.33

24.02

mg/l

0.54

238

(3044927) Protein electrophoresis panel - Urine

214

1.88

3.89

1.2

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

172

1.98

3.85

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.30

3.84

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

338

2364

1.25

3.84

1.8

2.3

1.33

1.21

g/l

1.60

296

2094

(3024891) Influenza virus A+B Ag [Presence] in Specimen

496

3612

1.20

3.83

1.2

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

292

1.73

3.81

1.4

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

292

1.73

3.81

1.4

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

292

1.73

3.81

1.4

2.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

121

727

1.45

3.78

2.3

2.4

2.88

1.59

ratio

0.62

375

(40757494) Bilirubin.total [Moles/volume] in Blood

280

1.75

3.77

2.2

3.1

49.29

89.13

umol/l

0.84

(40768443) Skin Pathology biopsy report

409

2928

1.22

3.76

1.1

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

502

1.55

3.76

1.1

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.70

3.73

1.1

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

244

2721

0.78

3.70

1.5

1.7

7.72

7.44

mmol/l

1.40

235

2610

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

837

0.60

3.69

1.2

1.3

65.36

68.07

ug/l

0.15

837

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

814

0.60

3.67

6.2

6.4

8.27

8.91

0.35

814

(40761995) Spermatozoa Progressive [#/volume] in Semen

814

0.60

3.67

3.1

3.2

43.59

44.85

0.17

814

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

270

1.75

3.65

1.0

0.22

0.42

u/ml

0.45

164

(3005082) Progesterone [Moles/volume] in Serum or Plasma

180

2086

0.75

3.64

1.3

1.5

28.05

35.49

nmol/l

2.53

153

1969

(3045683) HLA typing for celiac disease panel - Blood or Tissue

147

923

1.39

3.62

1.0

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

129

2.10

3.58

1.1

0.95

3.70

u/ml

1.34

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

183

1.91

3.58

1.3

1.4

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

298

1.70

3.57

1.0

1.1

0.81

1.04

u/ml

0.12

142

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

124

758

1.43

3.56

1.0

1.1

1.21

1.03

u/l

0.67

278

(44806420) Estimation of glomerular filtration rate

1084

0.66

3.56

1.9

1.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

145

913

1.39

3.52

1.3

184.32

198.88

pmol/l

0.41

145

913

(3001019) Free T4 and TSH panel - Serum or Plasma

716

7159

0.86

3.52

1.5

—

(3018001) Oat IgE Ab [Units/volume] in Serum

136

2.05

3.51

1.0

0.27

1.12

u/ml

0.60

(3006922) Hepatitis E virus Ab [Presence] in Serum

145

914

1.39

3.50

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

204

1.84

3.46

1.5

2.2

—

(3008037) Lactate [Moles/volume] in Venous blood

157

1005

1.37

3.46

2.6

2.9

1.31

1.40

mmol/l

0.63

145

982

(4195642) Thrombophilia screening test

256

1761

1.27

3.39

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

159

1024

1.36

3.38

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

192

1274

1.32

3.35

1.6

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

182

1.87

3.32

1.6

1.4

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

273

1.69

3.26

1.0

1.1

0.09

0.55

u/ml

1.76

132

(3000475) Leukocytes [#/volume] in Synovial fluid

172

1130

1.33

3.23

1.8

1.7

7857.27

11753.50

e6/l

1.10

121

813

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

153

1.94

3.22

1.1

1.2

12.10

36.54

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

153

1.94

3.22

1.1

1.2

11.12

26.04

u/ml

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

147

1.96

3.22

1.5

1.2

0.22

0.61

iu/ml

2.29

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1181

9305

1.12

3.17

2.8

1.79

1.32

ug/l

0.30

1050

8561

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

118

2.07

3.17

2.2

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

296

2093

1.24

3.13

1.7

2.1

10.28

10.54

mg/l

0.30

271

2000

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

155

1.91

3.11

1.1

1.0

67.81

75.87

ug/l

0.51

135

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

155

1.91

3.11

1.1

1.0

0.78

1.10

u/ml

0.20

143

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

149

1.93

3.11

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

199

1.80

3.11

1.5

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

199

1.80

3.11

1.5

2.3

—

(3007700) Barley IgE Ab [Units/volume] in Serum

2.18

3.09

1.0

0.23

15.07

u/ml

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

263

1839

1.25

3.08

1.1

2.54

2.56

0.01

364

(3032057) Clostridioides difficile [Presence] in Stool

2.36

3.07

1.7

2.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

366

1.57

3.07

1.0

1.1

3.33

4.37

iu/ml

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

271

1902

1.25

3.07

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

175

1.84

3.05

1.1

1.0

1.35

2.02

u/ml

0.28

141

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

124

783

1.38

3.02

1.1

—

0.35

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

115

2.05

2.99

1.3

1.4

389.92

461.57

pmol/l

0.21

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.67

2.95

2.7

1.9

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

129

825

1.37

2.92

1.2

1.3

344.00

246.78

titre

0.33

152

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

194

1318

1.29

2.90

1.1

93.14

94.89

0.40

180

1241

(3002621) Streptococcal DNAse B [Units/volume] in Serum

147

1.90

2.89

1.2

1.1

353.40

312.00

u/ml

—

(3013931) Oligosaccharides [Presence] in Urine

5.55

2.86

1.1

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

298

1.61

2.84

1.0

1.1

0.49

4.76

u/ml

1.08

137

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

402

1.52

2.82

1.1

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

3.17

2.80

1.1

1.3

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

155

1.86

2.80

1.6

1.7

2.31

2.28

mg/l

0.01

113

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

155

1.86

2.80

1.6

1.7

0.93

1.64

mg/l

1.06

105

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

155

1.86

2.80

1.6

1.7

1.29

1.35

mg/l

0.08

117

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

155

1.86

2.80

1.6

1.7

2.78

2.72

mg/l

0.02

113

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

155

1.86

2.80

1.6

1.7

2.90

4.44

mg/l

0.82

101

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

155

1.86

2.80

1.6

1.7

1.51

2.14

mg/l

0.42

113

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

155

1.86

2.80

1.6

1.7

1.76

1.46

mg/l

0.13

111

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

155

1.86

2.80

1.6

1.7

0.48

1.00

mg/l

1.57

111

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

155

1.86

2.80

1.6

1.7

1.42

1.37

mg/l

0.02

101

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

155

1.86

2.80

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

226

1.70

2.79

1.0

0.20

0.02

u/ml

0.43

140

(3008116) Ketones [Moles/volume] in Urine by Test strip

187

1.77

2.78

1.3

1.5

0.39

0.54

mmol/l

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

220

1.71

2.76

1.4

1.3

18.00

16.31

u/ml

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.24

2.76

8.2

7.1

5.13

6.19

mmol/l

1.67

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

426

1.50

2.74

2.0

1.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

577

1.42

2.73

2.1

2.8

2.70

11.93

nmol/l

0.47

553

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

8.72

2.73

9.2

4.4

205.20

193.60

mg/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

856

0.67

2.70

1.6

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

223

1.68

2.65

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

100

625

1.40

2.64

1.2

—

(3033099) Centromere Ab [Titer] in Serum

178

1.76

2.62

1.0

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

159

1.81

2.61

1.6

1.7

1.40

1.61

mg/l

0.11

109

(44790049) Parainfluenza type 3 nucleic acid detection

163

1100

1.30

2.60

2.0

1.7

—

(44790047) Parainfluenza type 1 nucleic acid detection

163

1100

1.30

2.60

2.0

1.7

—

(44806118) Parainfluenza type 4 nucleic acid detection

163

1101

1.29

2.59

2.0

1.7

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

116

1.96

2.58

1.5

1.2

343.41

183.09

mg/l

0.43

(44790048) Parainfluenza type 2 nucleic acid detection

163

1102

1.29

2.57

2.0

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

286

1.59

2.56

1.6

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

384

1.50

2.54

1.7

2.4

115.54

117.67

ng/l

0.06

322

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

251

1791

1.23

2.51

1.2

1.1

114.52

114.37

0.03

230

1638

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

386

1.49

2.49

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

269

1936

1.22

2.48

1.3

3.60

4.29

u/ml

0.66

138

964

(3020491) Glucose [Moles/volume] in Blood

108

692

1.36

2.48

1.6

6.08

5.75

mmol/l

0.58

602

(3007456) Orange IgE Ab [Units/volume] in Serum

2.49

2.44

1.1

1.0

0.09

0.11

u/ml

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

367

1.50

2.43

3.6

5.3

—

(40768441) Liver Pathology biopsy report

562

1.40

2.42

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

236

1.63

2.41

1.8

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

305

1.55

2.40

1.6

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

171

1177

1.27

2.37

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

477

1.43

2.36

1.6

1.9

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

134

896

1.31

2.33

1.5

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

977

7759

1.11

2.32

1.4

1.3

214.54

232.91

miu/ml

0.80

380

3996

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

502

1.41

2.29

1.2

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

154

1052

1.28

2.29

1.1

7.73

6.31

iu/ml

0.31

289

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

239

1719

1.22

2.25

1.6

1.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.14

2.21

1.2

1.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

111

1.89

2.19

1.0

0.64

0.73

umol/24h

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

633

1.35

2.18

1.1

1.5

—

13.44

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.00

2.16

1.1

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

148

1015

1.27

2.15

1.9

1.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

237

1.58

2.15

1.0

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

106

1.89

2.12

1.6

1.4

12.20

10.95

pmol/l

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.02

2.12

2.1

2.0

33.11

36.85

umol/l

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.36

2.06

2.4

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.00

2.04

1.4

1.2

42.83

39.33

g/l

0.49

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

130

0.33

2.01

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

214

1.59

2.00

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

273

2016

1.18

1.98

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

465

1.39

1.98

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

313

1.48

1.97

1.6

1.5

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

436

1.40

1.97

1.6

38.29

40.59

0.19

281

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

188

1.62

1.96

1.0

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

3.39

1.96

1.0

1.1

0.01

0.74

u/ml

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

202

1.60

1.95

1.1

0.74

8.74

u/ml

0.55

116

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

237

1.55

1.93

1.0

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

149

1.70

1.92

1.6

2.1

6.39

342863.36

nmol/l

1.15

126

(3034891) Synovial lining cells/cells in Synovial fluid

231

1.55

1.90

1.4

1.5

2.17

5.56

1.44

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.46

1.90

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

245

0.50

1.89

1.1

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

218

1.56

1.88

1.0

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

124

1.76

1.87

1.2

1.3

64.48

61.52

ug/l

0.27

124

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.93

1.87

1.1

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

161

1137

1.24

1.87

3.8

4.1

13.48

32.47

u/ml

0.66

161

1120

(1617658) Protocol used for examination of sentinel lymph nodes

322

0.57

1.85

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

226

1.54

1.84

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.40

1.81

3.0

4.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

159

1.65

1.79

1.1

1.0

—

(21494434) Karyotype in Bone marrow

349

1.43

1.79

1.4

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.79

1.78

1.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

2.79

1.78

1.0

13.29

12.37

u/ml

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

273

2038

1.17

1.78

1.3

3.27

3.61

u/ml

0.16

105

854

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

208

1.55

1.75

2.4

3.4

0.93

1.00

0.14

208

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

243

1.51

1.75

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

351

1.42

1.75

1.4

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

351

1.42

1.75

1.4

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

351

1.42

1.75

1.4

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

597

1.32

1.74

1.8

2.0

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

174

1.60

1.74

1.6

1.7

10.26

8.53

u/ml

0.07

146

(3011325) HIV 1+2 Ab [Presence] in Serum

1.99

1.74

1.1

0.10

0.08

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

181

1.59

1.73

2.0

3.0

17.50

35.38

mg/l

0.90

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

209

1.54

1.72

1.1

13.24

10.08

u/ml

0.33

128

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

345

1.42

1.72

1.0

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

3.27

1.68

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1073

0.78

1.68

3.1

3.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

354

0.61

1.66

1.0

1.1

1.19

1.17

mom

0.04

354

(3024869) Neuronal Ab [Presence] in Serum

2.03

1.61

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.77

1.60

2.1

2.2

4.43

2.75

mu/l

—

(3028433) Virus identified in Specimen by Culture

270

1.45

1.60

1.1

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

293

1.43

1.57

1.6

7.35

6.12

u/l

0.28

238

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

182

0.48

1.56

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

347

2667

1.14

1.56

1.8

1.9

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.29

1.55

1.3

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

112

779

1.26

1.54

2.8

2.9

7.03

7.16

mmol/l

0.16

104

764

(3017569) Oxygen content in Arterial blood

181

1.54

1.51

1.8

2.7

17.74

16.75

0.96

181

(3044941) Cell count panel - Synovial fluid

123

869

1.24

1.49

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.83

1.48

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

127

1.65

1.48

3.0

2.8

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.54

1.45

2.9

5.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

206

1533

1.17

1.45

2.9

22.44

24.96

mg/l

0.51

125

982

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.24

1.44

1.0

19.50

15.72

u/l

—

(3014271) Vancomycin [Susceptibility]

108

1.70

1.44

2.3

2.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

141

1015

1.21

1.44

3.7

2.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

219

1.47

1.44

3.3

2.8

0.59

0.62

mmol/l

1.13

219

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.81

1.43

1.1

—

(4035726) Immunohistochemistry procedure

542

4301

1.10

1.42

1.5

1.4

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

3.11

1.41

1.2

199.20

252.14

nmol/l

—

(3020876) Protein [Mass/time] in 24 hour Urine

526

1.29

1.40

2.6

2.7

2.28

1.73

g/24h

0.78

339

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

331

1.37

1.38

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

244

1.43

1.35

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.61

1.35

1.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

569

1.27

1.33

1.7

1.6

52.94

48.70

0.39

383

(3045142) Bone marrow Pathology biopsy report

500

1.29

1.33

1.5

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.13

1.30

4.8

6.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

305

1.37

1.30

2.9

1.7

1030.00

18662.46

u/ml

—

(4268621) Lupus anticoagulant assay

195

1462

1.16

1.29

2.3

2.4

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

328

1.36

1.29

1.8

1.7

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

1.85

1.28

1.4

1.82

1.66

ml/s/173m2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

113

808

1.22

1.27

1.6

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

125

903

1.21

1.27

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

556

4450

1.09

1.25

2.8

2.5

6.98

5.44

umol/l

0.93

414

3334

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

451

0.71

1.24

5.3

8.4

11.71

48.19

ug/l

0.58

336

(3004451) EKG impression Narrative

169

1.50

1.24

1.1

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

106

755

1.23

1.24

1.3

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.00

1.24

1.1

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.72

1.24

1.0

2.80

3.25

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

148

1.53

1.24

1.2

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.74

1.23

26.9

5.5

102.31

101.71

g/l

0.05

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.38

1.21

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

563

1.26

1.19

1.9

2.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

588

1.25

1.17

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

201

1.43

1.15

1.6

1.7

22.92

101.46

ug/min

1.12

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

457

1.28

1.15

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

350

1.32

1.15

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

205

0.59

1.13

1.2

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

202

1.42

1.13

3.2

2.63

5.16

0.54

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.63

1.12

1.5

1.6

0.50

0.43

ug/l

0.35

(3036071) Salmonella sp Ab [Titer] in Serum

444

1.28

1.11

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

248

1.37

1.09

1.3

1.5

20479.42

2809.70

e6/l

0.76

165

(3042631) Mycobacterium sp identified in Specimen

401

1.28

1.06

5.6

2.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

205

1.40

1.06

1.3

1.6

11.52

8.84

ug/l

1.82

205

(3052592) Norovirus Ag [Presence] in Stool

1.63

1.05

1.0

1.5

—

(3037756) Immunofixation for Serum or Plasma

479

1.26

1.05

1.7

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

518

1.25

1.05

1.4

1.2

—

(3004775) Volume in Urine collected for unspecified duration

310

1.32

1.05

1.7

2.5

626.29

635.33

0.05

244

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.01

1.05

1.0

—

(3022689) Creatine [Moles/volume] in Urine

191

1.42

1.04

1.2

1.5

7.71

10.20

mmol/l

2.30

191

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

155

1.46

1.03

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

120

1.53

1.01

1.4

1.6

444.66

102.67

mu/l

0.40

100

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

587

5489

0.93

1.00

2.1

0.47

0.60

ug/l

6.80

284

2139

(3003434) Protein [Mass/volume] in Pleural fluid

245

1.35

0.99

1.3

1.4

40.52

36.76

g/l

1.11

226

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

186

1424

1.14

0.99

1.4

—

(40768795) Lymph node Pathology biopsy report

598

0.79

0.99

1.2

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

128

1.50

0.99

1.0

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

159

1205

1.15

0.98

1.1

—

(3012441) Differential panel - Pleural fluid

216

1.37

0.98

1.3

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

268

2101

1.11

0.97

2.6

33.56

25.18

iu/ml

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

277

1.32

0.96

1.3

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

262

1.33

0.96

2.0

3.5

1.81

1.88

ratio

0.16

240

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.91

0.94

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

301

1.30

0.94

2.8

2.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

301

1.30

0.94

2.8

2.3

—

(3017704) Immunofixation for Urine

130

1.48

0.93

2.2

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

152

1.43

0.92

1.1

1.2

—

(3003577) Lead [Moles/volume] in Blood

109

1.52

0.92

1.2

1.4

0.68

0.20

umol/l

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

206

1598

1.13

0.91

1.5

1.6

7.72

6.98

mmol/l

2.18

199

1581

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.94

0.89

1.0

—

8.75

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.74

0.88

1.0

1.2

—

(21494814) CD8 cells/Lymphocytes in Specimen

329

1.27

0.85

2.1

2.3

26.19

28.87

1.10

329

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.61

0.85

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

138

1375

0.87

0.85

1.6

1.8

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.78

0.85

1.0

5.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

215

1.34

0.84

1.2

1.5

39147.21

30102.23

e6/l

0.21

121

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.71

0.83

1.5

1.7

—

(3012565) Volume of 24 hour Urine

316

1.27

0.81

1.6

2.2

2018.76

2134.09

0.24

302

(3023419) Bacteria identified in Sputum by Culture

489

1.21

0.81

3.7

3.4

—

(3001729) Color of Synovial fluid

1.87

0.81

2.5

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

445

0.78

0.80

2.0

1.3

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.80

0.0

1.0

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.60

0.78

1.8

1.3

1.10

1.64

mg/l

1.83

(3044316) Mercury [Moles/volume] in Urine

0.00

0.78

0.0

2.5

—

7.35

—

(3016750) Collection duration of Urine

272

1.28

0.77

1.7

2.5

530.65

513.94

min

0.42

223

(3030313) Adrenal Ab [Titer] in Serum

226

1.31

0.77

1.0

1.2

—

37.67

titre

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.18

0.76

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

194

1875

0.90

0.75

1.5

1.6

6.99

6.40

mmol/l

2.28

185

1731

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.50

0.75

1.0

1.1

90.00

92.22

titre

0.04

(3045788) Cell count panel - Pleural fluid

212

1.32

0.75

1.4

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

2.08

0.74

1.6

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

108

1.45

0.74

4.0

3.6

4.11

28.18

ug/l

0.55

108

(42870560) Thyrotropin [Units/volume] in Cord blood

376

1.23

0.73

1.0

8.45

8.67

mu/l

0.12

312

(3022475) Manganese [Moles/volume] in Blood

1.63

0.73

1.1

1.3

0.16

umol/l

—

(40762887) Creatinine [Moles/volume] in Blood

1.98

0.72

1.4

1.1

—

(3006598) pH of Arterial cord blood

330

1.24

0.72

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

330

1.24

0.72

1.0

6.77

7.28

kpa

1.08

286

(3021706) Oxygen [Partial pressure] in Arterial cord blood

323

1.24

0.70

1.0

3.56

3.45

kpa

0.11

276

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

125

960

1.14

0.70

2.5

4.8

54.91

105.25

u/ml

1.17

335

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

154

1.36

0.70

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

154

1.36

0.70

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

154

1.36

0.70

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

154

1.36

0.70

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

548

4510

1.06

0.69

1.7

1.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.49

0.69

1.2

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.49

0.69

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.49

0.69

1.0

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.51

0.68

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

251

2008

1.09

0.68

1.2

1.1

—

(40763590) HLA-DQ beta [Type]

1.65

0.67

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.65

0.67

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.54

0.67

1.0

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.82

0.67

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

118

1.40

0.67

5.3

4.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

430

1.20

0.65

1.9

2.0

134.43

135.92

au/ml

0.01

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.74

0.64

1.0

1.3

191.56

440.03

nmol/l

—

(3020650) Glucose [Presence] in Urine

391

1.20

0.64

1.5

1.4

0.06

0.02

estimate

0.24

391

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

145

1407

0.90

0.64

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

121

937

1.13

0.62

1.7

2.1

8.52

2.76

u/ml

0.66

322

(3004959) Base excess in Arterial cord blood by calculation

329

1.22

0.62

1.0

-1.81

-1.97

mmol/l

0.04

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

385

1.20

0.61

1.9

1.8

2.91

2.17

u/field

0.38

243

(44806071) Cardiolipin IgM antibody measurement

181

1.30

0.61

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.58

0.61

1.0

1.2

—

(3000012) Reticulocyte production index

507

1.17

0.60

1.7

1.9

0.83

0.91

0.47

281

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

121

1.37

0.59

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

331

1.21

0.59

1.6

1.5

2.90

3.59

u/field

0.25

253

(3024263) Appearance of Synovial fluid

221

1.26

0.59

1.9

2.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

167

1.31

0.58

2.8

3.0

0.92

0.87

nmol/l

0.10

122

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.74

0.58

2.8

7.6

—

(3016228) CD19 cells/cells in Blood

316

1.21

0.58

2.1

2.3

9.98

10.07

0.02

311

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

272

2203

1.08

0.58

1.1

3.08

2.86

eliau/ml

0.14

118

1136

(3038071) Oxygen [Partial pressure] in Mixed venous blood

152

1.32

0.58

21.3

6.6

5.14

5.56

kpa

0.52

152

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.48

0.57

3.1

3.4

—

(40765096) Chromosome analysis panel by Banding

145

1.32

0.56

1.0

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.44

0.56

1.0

1.1

—

(3012898) Urea [Moles/volume] in Urine

1.41

0.55

1.6

2.2

160.42

188.00

mmol/l

0.29

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

146

1.31

0.54

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

595

1.14

0.53

1.2

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

1.40

0.51

1.3

1.2

5.84

2.81

—

(3032868) Hemoglobin electrophoresis panel in Blood

179

1.27

0.51

1.4

1.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

148

1.30

0.51

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

378

1.18

0.50

2.4

2.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

258

1.22

0.50

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

3911

33601

1.02

0.50

2.2

1.9

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

219

1.23

0.49

1.1

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.39

0.48

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

220

1.23

0.48

2.3

2.03

1.72

ratio

0.73

214

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

125

0.70

0.47

1.7

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.41

0.46

1.7

1.5

278.83

281.92

umol/24h

0.02

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

128

1.29

0.44

2.2

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

127

1012

1.09

0.44

2.4

2.7

101.55

150.57

ug/min

0.92

688

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

111

1062

0.91

0.43

1.2

1.3

658.33

1041.80

titre

1.30

189

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

129

1.28

0.42

12.8

3.9

—

(3003157) Bacteria [#/volume] in Mother's milk

0.64

0.42

2.8

6.9

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

3242.86

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

172

1610

0.93

0.41

2.0

646.74

756.26

pmol/l

0.07

209

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.41

0.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

126

1193

0.92

0.40

1.2

1.3

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.4

—

(3016135) IgD [Mass/volume] in Serum

1.45

0.40

1.4

1.3

57.26

57.49

mg/l

—

(4015189) Microbial culture of sputum

1.38

0.38

1.8

3.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.32

0.35

1.1

—

(40760410) HLA-B [Type] by High resolution

1.41

0.35

1.0

—

(40760409) HLA-A [Type] by High resolution

1.41

0.35

1.0

—

(3013862) HLA-DP [Type]

1.41

0.35

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

151

1230

1.07

0.34

3.5

3.9

32.26

358.63

u/ml

1.82

134

1065

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

246

2036

1.05

0.34

1.4

1.5

56.36

65.21

pmol/l

0.42

235

1963

(4281824) Cell count and differential, peritoneal fluid

509

0.89

0.33

1.2

1.1

—

(3013466) aPTT in Blood by Coagulation assay

1.30

0.33

1.2

33.83

36.36

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

322

2687

1.05

0.32

1.1

—

0.83

—

(3022670) pH of Venous cord blood

111

1.26

0.32

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

543

4878

0.97

0.30

1.4

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

113

1.23

0.28

1.7

1.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

759

1.08

0.28

1.3

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

342

1.12

0.28

1.1

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.27

0.27

1.0

1.3

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.25

0.27

1.1

0.01

2.07

u/ml

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

488

4127

1.03

0.27

1.9

2.1

28.78

31.59

u/ml

0.37

473

3979

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.70

0.26

1.6

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

730

1.07

0.25

2.6

3.1

168.98

124.89

au/ml

0.36

116

(3050794) Legionella sp Ab [Presence] in Serum

1.21

0.25

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

232

0.86

0.24

1.0

5.16

7.24

u/ml

0.43

232

(3005532) Lymphocytes/Leukocytes in Pleural fluid

1.17

0.24

1.3

42.22

53.46

—

(4211845) Urine protein measurement

430

1.09

0.24

2.3

2.1

—

(3013762) Body weight Measured

1.32

0.23

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

1.32

0.23

2.6

3.6

10.28

6.83

mmol/l

—

(4133840) Spirometry

276

0.88

0.22

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

310

2615

1.03

0.22

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

466

0.92

0.22

6.2

7.3

5806.70

6951.25

u/ml

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.21

0.0

1.1

—

42.78

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.21

0.0

1.1

—

0.56

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.26

0.21

2.5

1.7

0.70

0.90

u/field

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

48.90

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

6.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

249

1.12

0.21

1.5

2.0

—

(3003694) ABO and Rh group [Type] in Blood

4243

37222

0.99

0.21

1.8

1.9

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.21

0.0

2.2

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

23.82

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

654

0.93

0.21

1.2

1.1

8.31

7.77

mm/h

0.25

654

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.20

0.0

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

510

1.08

0.20

2.7

2.8

44.96

44.32

0.10

275

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

367

1.09

0.20

1.1

19.00

34.25

iu/ml

3.45

367

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

102

841

1.06

0.20

1.1

1.2

1.06

1.05

ratio

0.32

716

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.22

0.19

1.7

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

385

3443

0.97

0.19

1.2

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

127

1.17

0.19

2.8

5.6

24.50

32.13

ug/min

—

(40765089) Chromosome analysis panel - Blood by G-banded

129

1176

0.96

0.18

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.22

0.18

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

198

0.88

0.18

1.4

1.5

5.74

5.26

mmol/l

1.17

198

(3000919) Neutrophils/Leukocytes in Pleural fluid

1.15

0.17

1.1

1.2

58.60

30.96

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.23

0.17

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.75

0.17

1.0

0.26

4.22

u/ml

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

114

0.84

0.16

2.3

1.8

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.14

0.16

1.3

1.1

—

42.40

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

484

1.06

0.15

2.5

2.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.78

0.14

1.4

1.6

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

290

1.08

0.14

1.2

1.8

—

264.00

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

185

0.89

0.14

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

0.85

0.13

2.8

2.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

388

3444

0.98

0.13

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

115

1.14

0.13

1.3

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

191

1.10

0.12

1.2

—

(40768806) Pleura Pathology biopsy report

183

1.10

0.12

1.3

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

184

1644

0.97

0.11

1.6

1.5

0.52

0.51

e9/l

0.20

184

1644

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

551

1.04

0.10

1.0

1.1

98.96

90.73

1.37

446

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

758

0.97

0.09

1.5

1.6

5.20

5.03

mmol/l

0.72

729

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.14

0.09

1.3

1.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

332

2937

0.98

0.09

3.0

4.2

6.47

27.50

ug/l

0.91

223

2002

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

596

1.04

0.09

2.6

2.5

9.38

9.54

mg/l

0.07

505

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

305

0.94

0.09

3.6

3.7

18.69

47.17

u/ml

1.88

305

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.11

0.09

1.0

—

(3019174) dRVVT (LA screen)

110

1.11

0.08

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

102

1.11

0.08

1.5

2.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

153

1.08

0.07

1.5

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

354

3049

1.01

0.07

1.9

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

311

0.95

0.07

3.1

2.8

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

442

3889

0.99

0.06

1.6

1.44

0.37

iu/ml

0.35

637

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

143

1229

1.01

0.04

1.1

13.05

14.57

u/ml

0.35

538

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

183

1.05

0.03

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

809

7027

1.00

0.03

2.6

2.5

20.63

21.64

0.58

161

1730

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.07

0.02

2.0

1.6

42.24

42.55

g/l

0.05

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

409

0.98

0.02

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

211

1.03

0.02

4.9

4.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

102

0.94

0.01

1.1

1.0

0.02

0.06

u/ml

0.87

102

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

608

0.99

0.01

1.2

8.50

17.19

u/ml

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

830

1.01

0.01

3.7

4.1

9.41

9.19

mg/l

0.12

685

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

0.95

0.00

2.6

2.0

88766.00

3210.96

e6/l

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

190

1.01

0.00

2.9

2.5

—

(40758292) HTLV I+II Ab panel - Serum

252

1.00

0.00

1.2

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

312

1.01

0.00

1.1

1.2

5.78

mmol/l

0.00

291

(3034426) Prothrombin time (PT)

363

1.01

0.00

1.2

27.60

28.38

0.54

363

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

1.01

0.00

1.1

1.3

66.60

62.25

—

(3009677) Dengue virus Ab [Presence] in Serum

1.04

0.00

1.0

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

579

1.01

0.00

2.1

4.2

146.59

128.30

u/ml

0.06

529

(40757373) Influenza virus identified in Isolate

109

0.96

0.00

1.3

1.7

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

125

0.98

0.00

1.1

1.4

77.00

44.71

—

(3010937) Rubella virus Ab [Presence] in Serum

167

0.99

0.00

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

1.00

0.00

1.3

1.7

—

(4038314) Semen analysis, post vasectomy

251

1.01

0.00

1.1

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.94

0.00

1.0

1.1

1.31

1.70

umol/24h

—

(3029612) Listeria sp Ab [Titer] in Serum

0.95

0.00

1.3

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

281.63

—

(3004768) Phthalic anhydride IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

11.4

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

1035.71

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

0.88

-0.00

8.3

7.9

12.14

10.92

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

1.7

—

2.49

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_BEHEMOCHILD and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_BEHEMOCHILD	2.453 [1.74, 3.45]	< 0.001
Birth year	0.997 [0.99, 1.01]	0.498

During the follow-up period (1.1.1998 — 31.12.2019), 833 out of 59417 females with F5_BEHEMOCHILD died.

Males

Parameter	HR [95% CI]	p-value
F5_BEHEMOCHILD	2.805 [2.38, 3.3]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.018

During the follow-up period (1.1.1998 — 31.12.2019), 1552 out of 90452 males with F5_BEHEMOCHILD died.

Mortality risk

Mortality risk for people of age

years, who have F5_BEHEMOCHILD.

N-year risk	Females	Males
1	0.254%	0.473%
5	1.587%	3.408%
10	3.706%	8.411%
15	7.211%	15.558%
20	13.156%	25.812%

Relationships between endpoints

↥

Index endpoint: F5_BEHEMOCHILD – Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints